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PREFACE
The Occupational Safety and Health Act of 1970 emphasizes the need 
for standards to protect the health and safety of workers exposed to an 
ever-increasing number of potential hazards at their workplace. The 
National Institute for Occupational Safety and Health has projected a 
formal system of research, with priorities determined on the basis of 
specified indices, to provide relevant data from which valid criteria for 
effective standards can be derived. Recommended standards for occupational 
exposure, which are the result of this work, are based on the health 
effects of exposure. The Secretary of Labor will weigh these 
recommendations along with other considerations such as feasibility and 
means of implementation in developing regulatory standards.
It is intended to present successive reports as research and 
epidemiologic studies are completed and as sampling and analytical methods 
are developed. Criteria and standards will be reviewed periodically to 
ensure continuing protection of the worker.
I am pleased to acknowledge the contributions to this report on 
epichlorohydrin by members of my staff and the valuable constructive 
comments by the Review Consultants on Epichlorohydrin, by the ad hoc 
committees of the American Conference of Governmental Industrial Hygienists 
and the American Occupational Medicine Association, and by Robert B. 
O'Connor, M.D., NIOSH consultant in occupational medicine. The NIOSH
iii
recommendations for standards are not necessarily a consensus of all the 
consultants and professional societies that reviewed this criteria document 
on epichlorohydrin. Lists of the NIOSH Review Committee members and of the 
Review Consultants appear on the following pages.
John F. Finklea, M.D.
Director, National Institute for 
Occupational Safety and Health
The Division of Criteria Documentation and Standards 
Development, National Institute for Occupational 
Safety and Health, had primary responsibility for 
development of the criteria and recommended standard 
for epichlorohydrin. The Division review staff for 
this document consisted of J. Henry Wills, Ph.D., 
Howard Spencer, Ph.D., Seymour Silver, Ph.D., and 
Frank L. Mitchell, D.O.
Stanford Research Institute (SRI) developed the 
basic information for consideration by NIOSH staff 
and consultants under contract No. CDC-99-74-31. 
Jerry LR Chandler, Ph.D., had NIOSH program 
responsibility and served as criteria manager.
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I. RECOMMENDATIONS FOR AN EPICHLOROHYDRIN STANDARD
The National Institute for Occupational Safety and Health (NIOSH) 
recommends that employee exposure to epichlorohydrin in the workplace be 
controlled by adherence to the following sections. The standard is 
designed to protect the health and safety of employees for up to a 10-hour 
workday, 40-hour workweek, over a working lifetime. Compliance with all 
sections of the standard should prevent adverse effects produced by 
exposure of employees to epichlorohydrin. Although the workplace
environmental limits are considered to be safe levels based on current 
information, they should be regarded as the upper boundary of exposure, and 
every effort should be made to maintain exposure as low as is technically 
feasible. The standard is measurable by techniques that are available and 
there is sufficient technology to permit compliance with the recommended 
standard. The standard will be subject to review and revision as 
necessary.
These criteria and the recommended standard apply to exposure of 
employees to solid, liquid, or gaseous 3-chloro-l,2-epoxypropane, hereafter 
referred to as "epichlorohydrin," either alone or in combination with other 
substances. Synonyms for epichlorohydrin include l-chloro-2,3- 
epoxypropane, (chloromethyl)ethylene oxide, chloromethyloxirane,
chloropropylene oxide, gamma-chloropropylene oxide, 3-chloro-l,2-propylene 
oxide, 2-chloromethyl-oxirane, alpha-epichlorohydrin, epichlorhydrin, and 
epichlorophydrin.
"Occupational exposure to epichlorohydrin" is defined as exposure to 
airborne epichlorohydrin at concentrations exceeding the action level. The
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"action level" is defined as one-half of the recommended time-weighted 
average (TWA) environmental concentration for epichlorohydrin. Exposure to 
airborne epichlorohydrin at concentrations equal to or less than one-half 
of the workplace environmental limit, as determined in accordance with 
Section 8, will not require adherence to the following sections except for 
2, 3, 4(a), 5(a,b,c,d), 6, and 7. If exposure to other chemicals also 
occurs, provisions of any applicable standard for the other chemicals shall 
also be followed.
Section 1 - Environmental (Workplace Air)
(a) Concentration
Occupational exposure to epichlorohydrin shall be controlled so that 
employees are not exposed to epichlorohydrin at concentrations greater than 
2 milligrams per cubic meter of air (approximately 0.5 parts per million 
parts of air by volume) determined as a TWA concentration for up to a 10- 
hour workday, 40-hour workweek, with a ceiling concentration of 19 
milligrams per cubic meter of air (approximately 5 parts per million parts 
of air by volume) as determined by a sampling time of 15 minutes.
(b) Sampling and Analysis
Procedures for sampling and analysis of environmental samples and 
calibration of equipment shall be as provided in Appendices I and II, or by 
any methods shown to be at least equivalent, in accuracy, sensitivity, and 
precision to the methods specified.
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Section 2 - Medical
Medical surveillance shall be made available to all persons subject 
to occupational exposure to epichlorohydrin as described below:
(a) Preplacement medical examinations shall include:
(1) Comprehensive medical and work histories.
(2) Complete physical examination, giving particular 
attention to the kidneys, liver, respiratory tract, and hematopoietic 
system. Additionally, employees shall be evaluated for complaints and 
evidence of eye, mucous membrane, or skin irritation. Further tests, such 
as determinations of the concentrations of serum glutamic-pyruvic 
transaminase (SGPT), serum glutamic-oxaloacetic transaminase (SGOT), and 
lactic dehydrogenase (LDH), may be considered by the responsible physician.
(3) An evaluation of the ability of the worker to use
respirators.
(b) Periodic examinations shall be made available on an annual 
basis. These examinations shall include, but shall not be limited to:
(1) Interim medical and work histories.
(2) Physical examination as outlined in paragraph (a) (2)
of this section. The responsible physician shall consider administering 
appropriate organ function tests.
(c) Proper medical management shall be provided for employees 
overexposed to epichlorohydrin. When there is known or suspected 
overexposure to epichlorohydrin, immediate first-aid measures shall be 
followed by prompt medical evaluation and followup assistance. First aid 
shall include removal of the employee from the area of excessive 
epichlorohydrin exposure, restoration of, or assistance in, breathing by
trained personnel, and treatment of chemical burns.
(d) The responsible physician shall advise the worker that
available information indicates that large doses of epichlorohydrin induce 
antifertility effects on rats; however, no effects on potency have been 
found. The relevance of this study to male or female workers has not yet 
been determined. It does, however, indicate that employers and workers 
should attempt to minimize exposures to epichlorohydrin whenever possible. 
If the physician becomes aware of any adverse effects on the reproductive 
systems of workers exposed to epichlorohydrin, the information shall be 
forwarded to the Director, National Institute for Occupational Safety and 
Health, as promptly as possible.
(e) Pertinent medical records shall be maintained and made
available to the designated medical representatives of the employer, of the 
employee or former employee, of the Secretary of Labor, and of the 
Secretary of Health, Education, and Welfare. These records shall be 
retained for 20 years following the employee's last occupational exposure 
to epichlorohydrin.
Section 3 - Labeling and Posting
(a) Labeling
Containers of epichlorohydrin shall carry a label stating:
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EPICHLOROHYDRIN
POISON! FLAMMABLE!
SKIN CONTACT CAUSES DELAYED BURNS
Avoid contact with eyes, skin, and clothing.
Avoid breathing vapor.
Use only with adequate ventilation.
Keep away from heat and open flame.
Keep container closed.
Do not take internally.
First Aid: In case of skin contact, immediately remove all contaminated
clothing, including footwear, wash skin with plenty of water for at least 
15 minutes and call a physician. In case of eye contact, flush eyes with 
water for 15 minutes and call a physician.
(b) Posting
Areas where epichlorohydrin is manufactured, stored, used, or handled
shall be posted with a sign reading:
EPICHLOROHYDRIN
POISON! FLAMMABLE!
SKIN CONTACT CAUSES DELAYED BURNS 
VAPOR IRRITATING TO EYES 
HARMFUL IF INHALED OR SWALLOWED
The sign shall be printed both in English and in the predominant 
language of non-English-reading workers, if any; the employer shall use 
these or other equally effective means to ensure that all employees know 
the hazards associated with epichlorohydrin and the locations of areas in 
which there is likely to be occupational exposure to epichlorohydrin.
Section 4 - Personal Protective Equipment
(a) Protective Clothing
(1) Chemical safety goggles and face shields shall be
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provided by the employer and shall be worn during any operation in which 
epichlorohydrin may splash into the eyes. Suitable eye protective devices 
shall conform to 29 CFR 1910.133.
(2) Aprons, suits, boots, or face shields shall be worn 
when needed to prevent skin contact with liquid epichlorohydrin. The 
protective clothing for this purpose shall be made of impervious material, 
such as polyethylene, polypropylene, or polyvinyl chloride (PVC). Use of 
protective clothing made of neoprene, rubber, or leather is unsuitable.
(b) Respiratory Protection
Engineering controls shall be used to maintain epichlorohydrin 
concentrations below the recommended environmental limits. Such control 
equipment shall be sparkproof. Compliance with the permissible exposure 
limit may not be achieved by the use of respirators except during the time 
necessary to install or test the required engineering controls, for 
nonroutine maintenance or repair activities in which brief exposures at 
concentrations in excess of the recommended limits may occur, and during 
emergencies when air concentrations of epichlorohydrin may exceed the 
recommended limits.
When a respirator is permitted by paragraph (b) of this section, it 
shall be selected and used pursuant to the following requirements:
(1) For the purpose of determining the type of respirator 
to be used, the employer shall measure, when possible, the concentration of 
airborne epichlorohydrin in the workplace initially and thereafter whenever 
process, worksite, or control changes occur which are likely to increase 
the epichlorohydrin concentrations; this requirement does not apply when 
only atmosphere-supplying, positive pressure respirators are used. The
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employer shall ensure that no worker is exposed to epichlorohydrin in 
excess of the recommended workplace environmental limits because of
improper respirator selection, fit, use, or maintenance.
(2) A respiratory protection program meeting the
requirements of 29 CFR 1910.134 shall be established and enforced by the 
employer.
(3) The employer shall provide respirators in accordance
with the provisions of both Table 1-1 and 30 CFR 11 and shall ensure that 
the employee uses the respirator provided.
(4) Respirators specified for use in higher concentrations 
of epichlorohydrin may be used in atmospheres of lower concentrations.
(5) The employer shall ensure that respirators are
adequately cleaned, and that employees are instructed in the use and the
testing for leakage of respirators assigned to them.
(6) Where an emergency which could result in employee
injury from overexposure to epichlorohydrin may develop, the employer shall
provide respiratory protection as listed in Table 1-1.
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TABLE 1-1
RESPIRATOR SELECTION GUIDE
Maximum Use
Concentration Respirator Type
Less than or 
equal to 25 ppm
(1) Gas mask with chin-style or 
front- or back-mounted organic va­
por canister
(2) Type C supplied-air respirator 
operated in the pressure-demand. 
(positive pressure) or continuous- 
flow mode
Less than or 
equal to 100 ppm
(1) Gas mask (full facepiece) with 
chin-style or front-mounted organ­
ic vapor canister with impervious 
plastic cover for head and neck
(2) Type C supplied-air respirator 
operated in the pressure-demand 
(positive pressure) or continuous- 
flow mode with a full facepiece and 
impervious plastic cover for head 
and neck
Less than or 
equal to 1,000 ppm
Type C supplied-air respirator with 
hood, helmet, or suit operated in 
the continuous-flow mode
Greater than 
1,000 ppm
(1) Self-contained breathing appa­
ratus with full facepiece operating 
either in the demand (negative 
pressure) mode or in the pressure- 
demand (positive pressure) mode 
worn under an impervious plastic 
suit with headpiece
(2) Combination Type C supplied- 
air respirator with full facepiece 
operated in the pressure-demand 
(positive pressure) mode and an 
auxiliary self-contained air supply 
worn under an impervious plastic 
suit with headpiece
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TABLE 1-1 (CONTINUED)
RESPIRATOR SELECTION GUIDE
Maximum Use 
Concentration Respirator Type
Emergency (no con­
centration limit)
(1) Self-contained breathing appa­
ratus in the pressure-demand (posi­
tive pressure) mode with full face- 
piece
(2) Combination supplied-air res­
pirator with an auxiliary self-con­
tained air supply and full face- 
piece operated in the pressure- 
demand (positive pressure) mode
Escape (no con­
centration limit)
(1) Gas mask (full facepiece) with 
chin- or front-mounted organic va­
por canister
(2) Self-contained breathing appa­
ratus with full facepiece operated 
either in the demand (negative 
pressure) mode or in the pressure- 
demand (positive pressure) mode
Section 5 - Informing Employees of Hazards from Epichlorohydrin
(a) Each employee working in an area where exposure to 
epichlorohydrin is likely, shall be informed of the signs and symptoms of 
overexposure, emergency and first-aid procedures, the hazards of chronic 
exposure, and precautions to ensure safe use of epichlorohydrin and to 
minimize exposure. All information shall be posted in the workplace and 
shall be readily accessible to the employee.
(b) Employers shall ensure that all such employees have current 
knowledge of job hazards, maintenance procedures, and cleanup methods, and
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that they know how to use respiratory protective equipment and protective 
clothing.
(c) Employees and members of emergency teams who work near 
epichlorohydrin systems or containers where a potential for emergencies 
exists shall participate in periodic drills simulating emergencies
appropriate to the work situation. Drills shall be held at intervals not
greater than 6 months. Drills should include, but should not be limited 
to:
Evacuation procedures.
Handling of spills and leaks, including decontamination.
Location and use of emergency firefighting equipment, and
handling of epichlorohydrin systems or containers 
in case of fire.
First-aid and rescue procedures, including prearranged 
procedures for obtaining emergency medical care.
Location, use, and care of protective clothing and 
respiratory protective equipment.
Location of shut-off valves or switches.
Location, purpose, and use of safety showers and eye­
wash fountains.
Operating procedures including communication procedures.
Entry procedures into confined spaces.
Deficiencies noted during drills shall be included in the continuing 
educational program together with the required remedial actions. Records 
of drills and training sessions shall be kept and made available for 
inspection by authorized personnel upon request.
(d) Information as required shall be recorded on the "Material 
Safety Data Sheet" shown in Appendix III, or on a similar form approved by 
the Occupational Safety and Health Administration, US Department of Labor.
Section 6 - Work Practices
(a) Engineering controls, such as process enclosure or local
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exhaust ventilation, shall be used to maintain epichlorohydrin 
concentrations at or within the recommended workplace environmental limits. 
Ventilation systems shall be designed to prevent the accumulation or
recirculation of epichlorohydrin in the workplace and to remove 
epichlorohydrin from the breathing zones of exposed workers. When used, 
exhaust ventilation systems discharging to outside air must conform with 
applicable local, state, and federal air pollution regulations.
Ventilation systems shall undergo regular preventive maintenance and
cleaning to ensure maximum effectiveness, which shall be verified by
periodic airflow measurements. Records of these measurements shall be 
maintained for at least 1 year.
(b) When an operation involves the use of epichlorohydrin in an 
open vessel, which is not part of an isolated system, continuous local 
exhaust ventilation shall be provided so that air movement is always from 
the work areas to the operation. Exhaust air shall not be discharged in 
the work areas and clean makeup air shall be introduced in sufficient 
volume to maintain the correct operation of the local exhaust system. 
Containers of epichlorohydrin shall be labeled in accordance with Section 3 
and shall be kept tightly closed at all times when not in use. Storage 
provisions are listed in 29 CFR 1910.106(a)19(iii). Containers shall be 
protected from heat, corrosion, mechanical damage, and sources of ignition.
(c) Any spilled epichlorohydrin shall be promptly cleaned up. 
During cleanup operations, complete skin and respiratory protective 
equipment shall be used. After a cleanup operation, the employee shall be 
required to shower upon removing the protective equipment. If 
epichlorohydrin is spilled on shoes made of leather, canvas, rubber, or of
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any other permeable material, the shoes shall be rendered unusable and 
discarded. If clothing is contaminated with epichlorohydrin, it shall be 
removed promptly and laundered thoroughly before reuse.
(d) Appropriate regulations for Class IC flammable liquids are
provided in 29 CFR 1910.106.
(e) Prior to maintenance work, sources of epichlorohydrin vapor
shall be eliminated to the extent feasible. The employees shall be 
provided with appropriate skin and respiratory protective equipment.
(f) Confined Spaces
(1) Entry into confined spaces, such as tanks, pits, tank 
cars, barges, process vessels, and tunnels, shall be controlled by a permit 
system. Permits shall be signed by an authorized employer representative 
certifying that preparation of the confined space, precautionary measures, 
and personal protective equipment are adequate, and that precautions have 
been taken to ensure that the prescribed procedures will be followed.
(2) Confined spaces which have contained epichlorohydrin 
shall be inspected and tested for oxygen deficiency, epichlorohydrin, and 
other contaminants, and, prior to entry by the employee, they shall be 
thoroughly ventilated, cleaned, and washed.
(3) Inadvertent entry of epichlorohydrin into the confined 
space while work is in progress shall be prevented by disconnecting and 
blocking of epichlorohydrin supply lines or by other appropriate means.
(4) Confined spaces shall be ventilated appropriately while 
work is in progress to keep the concentration of epichlorohydrin at or 
below the recommended environmental limits and to ensure an adequate supply 
of oxygen.
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(5) Individuals entering confined spaces where they may be
exposed to epichlorohydrin shall wear either a combination Type C supplied-
air respirator operated in the continuous-flow (positive pressure) mode or 
an auxiliary breathing air supply operated in the pressure-demand (positive 
pressure) mode equipped with a full facepiece, or a self-contained
breathing apparatus operated in the pressure-demand (positive pressure) 
mode. Each individual shall also wear a suitable harness with lifelines 
tended by another employee outside the space who shall also be equipped 
with the necessary protective equipment, including a self-contained 
breathing apparatus which operates in the pressure-demand (positive 
pressure) mode and has a full facepiece. Communication (visual, voice,
signal line, telephone, radio, or other suitable means) shall be maintained 
by the standby person with the employees inside the enclosed spaces.
(g) For all work areas where epichlorohydrin is used, procedures 
as specified in this section, as well as any other procedures appropriate 
for a specific operation or process, shall be formulated in advance. 
Employees shall be comprehensively instructed in the implementation of 
emergency procedures.
(1) Procedures shall include prearranged plans for
obtaining emergency medical care and for transportation of injured workers
to medical facilities.
(2) Firefighting procedures shall be established and drills 
conducted. These shall include procedures for emergencies involving fire 
and release of epichlorohydrin vapor. In case of fire, epichlorohydrin 
sources shall be shut off or removed as soon as feasible. Containers of
epichlorohydrin shall be removed or cooled with water spray as soon as
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feasible. Chemical foam, carbon dioxide, or dry chemicals shall be used 
for extinguishing epichlorohydrin fires. Proper respiratory protective 
devices and protective clothing shall be worn to protect against 
epichlotohydrin, acid gases, and other combustion products of 
ep ichlorohydr in.
(3) Approved eye, skin, and respiratory protective devices 
as specified in Section 4 shall be used by all personnel who are essential 
to emergency operations.
(4) During emergencies, employees not essential to the
emergency operations shall be evacuated. A warning system informing the
employees of the evacuation shall be established. Boundaries of areas 
where this emergency occurred shall be delineated, posted, and secured as
soon as feasible. Entry into hazardous areas shall be prohibited to
employees not essential to the emergency operations.
(5) Personnel trained and knowledgeable in the safety 
procedures and adequately protected against the attendant hazards shall 
shut off sources of epichlorohydrin, clean up spills, and immediately 
repair leaks.
Section 7 - Sanitation
(a) Food preparation, storage, dispensing, and eating shall be
prohibited in posted work areas.
(b) Smoking shall be prohibited in posted work areas.
(c) Safety showers and eyewash fountains shall be installed in and
adjacent to posted work areas.
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(d) Shower facilities shall be made available to employees who may 
have occupational exposure to epichlorohydrin.
Section 8 - Monitoring and Recordkeeping Requirements
Workers will not be considered to have occupational exposure to 
epichlorohydrin if the environmental concentrations, as determined by an 
industrial hygiene survey conducted within 6 months of the promulgation of 
a standard, do not exceed one-half the recommended TWA environmental limit, 
ie, the action level. Surveys shall be repeated at least once every 3 
months and within 30 days after any process change likely to result in 
increases of airborne concentrations of epichlorohydrin. Records of these 
surveys, including the basis for concluding that airborne concentrations of 
epichlorohydrin are at or below the action level, shall be maintained. If 
the survey indicates that airborne concentrations of epichlorohydrin exceed 
the action level, then the following requirements apply:
(a) Personal Monitoring
(1) A program of personal monitoring shall be instituted to 
identify and measure, or permit calculation of, the exposure of all 
employees who are occupationally exposed to epichlorohydrin. Interim 
monitoring of employee exposure to airborne concentrations of 
epichlorohydrin shall be conducted at least every 3 months. If monitoring 
of an employee’s exposure to epichlorohydrin reveals that the employee is 
exposed at concentrations in excess of the recommended TWA environmental 
limit, the exposure of that employee shall be measured at least once every 
30 days, control measures shall be initiated, and the employee shall be 
notified of the exposure and of the control measures being implemented to
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correct the situation. Such monitoring shall continue until two 
consecutive samplings, at least 1 week apart, indicate that the employee’s 
exposure no longer exceeds the TWA environmental limit recommended in 
Section 1(a). Quarterly monitoring may then be resumed.
(2) In all personal monitoring, samples of airborne
epichlorohydrin that will provide upon analysis an accurate representation 
of the concentration of epichlorohydrin in the air the worker breathes 
shall be collected. Procedures for sampling, calibration of equipment, and 
analysis of epichlorohydrin in samples shall be as provided in Section 
1(b).
(3) For each TWA determination, a sufficiently large number
of samples shall be taken to characterize each employee's exposure during
each workday. Variations in work and production schedules shall be 
considered in deciding when samples are to be collected. The number of 
representative TWA determinations for an operation or process shall be 
based on the variations in location and job functions of employees in 
relation to that operation or process.
(b) Recordkeeping Procedures
Records shall be maintained and shall include sampling and analytical 
methods, type of respiratory protective device used, and TWA and ceiling 
concentrations found. Each employee shall have access to data on personal 
environmental exposures and records of such data shall be included in his 
medical records. Pertinent records of required medical examinations,
including records of occupational accidents, and environmental exposures 
within the workplace shall be maintained for 20 years after the worker's 
last occupational exposure to epichlorohydrin and shall be available to the
designated medical representatives of the Secretary of Labor, of the 
Secretary of Health, Education, and Welfare, of the employer, and of the 
employee or former employee.
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II. INTRODUCTION
This report presents the criteria and the recommended standard based 
thereon which were prepared to meet the need for preventing occupational 
diseases arising from exposure to epichlorohydrin. The criteria document 
fulfills the responsibility of the Secretary of Health, Education, and 
Welfare, under Section 20(a)(3) of the Occupational Safety and Health Act 
of 1970 to "...develop criteria dealing with toxic materials and harmful 
physical agents and substances which will describe...exposure levels at 
which no employee will suffer impaired health or functional capacities or 
diminished life expectancy as a result of his work experience."
The National Institute for Occupational Safety and Health (NIOSH), 
after a review of data and consultation with others, formalized a system 
for the development of criteria upon which standards can be established to 
protect the health of workers from exposure to hazardous chemical and 
physical agents. These criteria for a standard for epichlorohydrin are
part of a continuing series of criteria developed by NIOSH. The proposed 
standard applies only to the processing, manufacture, and use of, or other 
occupational exposure to, epichlorohydrin as applicable under the 
Occupational Safety and Health Act of 1970. The standard was not designed 
for the population-at-large, and any extrapolation beyond occupational 
exposures is not warranted. It is intended to (1) protect against the 
development of acute and chronic effects of epichlorohydrin exposure, (2) 
protect against local effects on the skin, (3) be measurable by techniques 
that are available to industry and government agencies, and (4) be
18
attainable with existing technology.
The development of the criteria for the recommended standard for 
occupational exposure to epichlorohydrin has elucidated the need for 
further research in the following areas: (1) further epidemiologic studies
of employees exposed to epichlorohydrin, (2) animal studies designed to 
determine the cumulative effects from inhalation of airborne 
epichlorohydrin at concentrations below 5 ppm, (3) studies on the mutagenic 
effects of epichlorohydrin in mammals, and (4) animal studies to 
investigate the carcinogenic effects from epichlorohydrin inhalation. To 
fill these information gaps, a concerted effort is required by those people 
who are involved with the health and safety of employees exposed to 
epichlorohydrin.
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III. BIOLOGIC EFFECTS OF EXPOSURE
Extent of Exposure
Epichlorohydrin (formula weight 92.53) is a colorless liquid at room 
temperature with a distinctive odor described as "ethereal," "chloroform­
like," and "garlic-like." [1] Its boiling point is 116.4 C and the vapor 
pressure at 29 C is 20 mmHg. [2] The low latent heat of vaporization of 
epichlorohydrin (9,060 cal/mole) [3] contributes to the rapid evaporation 
of spills. Other physical properties are given in Table XIII-1. [2,4,5]
Epichlorohydrin is a reactive molecule which may form covalent bonds 
under biologic conditions. [6,7] In reactions with alcohols, amines, 
thiols, and other nucleophilic biochemical constituents of the cell, the 
epoxide ring opens and forms a new, stable, covalent carbon-hetero atom 
bond as shown in the reaction In Figure XIII-1. The initial reaction 
product may undergo a second nucleophilic reaction to form stable, covalent 
cross-linking bonds between two molecules either by direct displacement of 
the chlorine atom or through the formation of an unstable, short-lived 
cyclic intermediate. [8] These cross-linking bonds may have a high degree 
of chemical stability, such as is typically found in epoxy resins. [4] The 
chemical characteristic of epichlorohydrin to react as a bifunctional 
alkylating agent is an intrinsic property of its molecular structure.
Biologic organisms contain many different chemical nucleophiles, such 
as alcohols, acids, amines, sulfhydryls, carbohydrates, lipids, proteins, 
ribonucleic acids, and deoxyribonucleic acids. [9] Epichlorohydrin has a 
greater tendency to react with more readily polarized groups, such as 
sulfhydryl groups, than with less readily polarized groups, such as
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hydroxyls. The half-life of epichlorohydrin in water at a pH of 7 is 36.3 
hours. [6] Although the half-life of epichlorohydrin in biologic tissues 
is not known, the known presence of large numbers of nucleophiles in tissue 
suggests that it is shorter than the half-life in water. Mammalian enzymes 
which catalyze the hydrolysis of epichlorohydrin, or otherwise degrade it, 
would further decrease the biologic half-life. Under hypothetical, 
constant, nonlethal exposure conditions, a steady-state concentration of 
epichlorohydrin would eventually be achieved in all tissues, resulting in a 
steady-state rate of alkylation of tissue constituents. For reviews of the 
pertinent literature, the reader is referred to Ross [6] and Loveless. [7]
Extent of Exposure
Epichlorohydrin is commercially synthesized from allyl chloride, [12] 
allyl alcohol, [12] dichlorhydrin-glycerine, [11,12] or propylene. [13] 
The total US production of epichlorohydrin was about 550 million pounds in 
1975. [14] Projected expansion plans, if accomplished, would increase 
total production to 715 million pounds by 1978. [14]
In 1969, the total US production of crude epichlorohydrin was about 
322 million pounds. [12] An estimated 58% of this was used in the 
manufacture of synthetic glycerine and 42% was processed to refined 
epichlorohydrin. [12] Refined epichlorohydrin is used in the manufacture 
of epoxy resins, surface active agents, pharmaceuticals, insecticides, 
agricultural chemicals, textile chemicals, coatings, adhesives, ion- 
exchange resins, solvents, plasticizers, [15] glycidyl esters, [16] 
ethynyl-ethylenic alcohol, [17] and fatty acid derivatives. [16] Most
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epoxy resin is synthesized by alkylating bisphenol A with epichlorohydrin.
[4 ]
A number of cases of dermal sensitization have been reported in
workers in the epoxy resin-producing and resin-using industries. [18-20]
Attempts to identify the causative agents have been only partially 
successful. [18-20] Traces of free epichlorohydrin have been found in the 
resin in the USSR [21] and Sweden (S Fregert, written communication, 
September 1975); however, a few case reports have indicated that 
epichlorohydrin itself is probably not the responsible chemical. [19,22]
In the United States, a hazard survey was conducted by NIOSH around 
electronic component-molding operations where several different epoxy 
resins were used. [23] Most of these resins were made from bisphenol A and 
epichlorohydrin and had to be heated prior to use. Environmental
monitoring using charcoal-tube and gas chromatography indicated that 
epichlorohydrin was not present in the air in any detectable quantity. The 
lowest limit of detection was 0.008 mg or approximately 0.02 mg/cu m (0.005 
ppm) .
NIOSH estimates that 50,000 employees may be exposed to
epichlorohydrin in the United States.
Historical Reports
The first report on epichlorohydrin toxicity was made by Von Kossa 
[24] in 1898. He found that, following dermal contact, epichlorohydrin 
induced transitory burning and slight irritation in human subjects. One 
person with sensitive skin developed an eczema lasting 3 weeks following a 
1-hour application of 0.5 g of epichlorohydrin. Von Kossa [24] also
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investigated the effects of epichlorohydrin on a dog, rabbits, pigeons, and 
frogs to evaluate its usefulness as an anesthetic agent. A dog was 
reported to have received a total of 381 g of epichlorohydrin within 7 days 
by an unspecified route and to have died on the eighth day. A swollen 
liver and edema of the superficial abdominal tissues were observed. 
Subcutaneous injection of 1.16 g of epichlorohydrin into a rabbit produced 
labored breathing, cyanosis, narcosis, and death in about an hour. At 
autopsy, emphysematous and hyperemic lungs were evident. Daily 
subcutaneous injections of 0.15 g of epichlorohydrin were administered to 
another rabbit for 7 days, and the animal died on the eighth day. 
Hemorrhages in the stomach, especially in the fundus, along with a seared 
appearance of the adjacent mucous membrane in the stomach were observed at 
autopsy. An unspecified amount of albumin was detected in the urine. When 
a cloth soaked in 5 cc of epichlorohydrin was placed next to a pigeon in a 
jar, sneezing, labored breathing, body trembling, narcosis, and death 
resulted within an hour. Another pigeon injected intramuscularly with 0.07 
g of epichlorohydrin on 2 consecutive days died on the second day. Autopsy 
revealed edema at the injection site, plethoric meningeal blood vessels, 
intestinal inflammation, and hemorrhage. The dorsal lymph sacs of two 
frogs were each injected with 0.15 g of epichlorohydrin. Exophthalmos and 
irregular respiration were observed. Although apparent recovery occurred 
within an hour after injection, both frogs died about 5 hours later. A 
third frog, whose heart had been exposed, was injected similarly with 0.15 
g of epichlorohydrin. The cardiac rate decreased from 40 to 34 
beats/minute within 20 minutes, and the animal died within 6 hours of 
epichlorohydrin administration. Von Kossa [24] believed that the severe
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irritating action of epichlorohydrin on the gastrointestinal tract would 
make it unsuitable as an anesthetic. He also indicated that its strong 
depressant effects on the heart and respiration would make it 
unsatisfactory for any use in medicine. The narcotic and the persisting 
dermal effects of epichlorohydrin, as well as the effects on respiration, 
liver, and gastrointestinal tract reported by Von Kossa [24] in 1898, have 
been confirmed repeatedly by other investigators. [25-32] These effects 
are further discussed in Animal Toxicity.
Effects on Humans
In 1964, Schultz [33] reported the case of a 39-year-old temporary 
worker exposed to a gust of epichlorohydrin from a presumably empty tank. 
He immediately experienced irritation of the eyes and throat, followed by 
facial swelling, nausea, vomiting, headache, and dyspnea. The following 
day, he went to the clinic where his liver was found to be enlarged. Two 
days after the exposure, a slight jaundice associated with a serum 
bilirubin of 3.44 mg% was observed. The accepted range of normal values 
for the concentration of bilirubin in serum is 0.1-1.2 mg%. [34] After 18 
days, his jaundice had subsided, but his liver was still slightly enlarged. 
Five months later, the same hospital conducted a medical evaluation of the 
man; the major findings were bronchitic alterations in the right lung, 
elevated blood pressure, and liver damage. Liver function was still 
abnormal, as indicated by elevated amounts of urobilin and urobilinogen in 
the urine. Eight months later, the man still had a serum bilirubin of 2.6 
mg% and abnormal amounts of urobilin and urobilinogen in the urine. Nearly 
2 years after the accident, the author [33] examined this worker. A liver
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biopsy indicated fatty changes, while delayed sulfobromophthalein (BSP) 
elimination, increased galactose excretion, and increased concentrations of 
urinary bile pigments indicated altered liver function. Hypertension 
(degree not reported) and chronic asthma-like bronchitis also were present. 
The author reported that other possible causes of liver damage, such as 
nutritional defects, alcoholism, diabetes, tuberculosis, and prior liver 
disease, were explored and ruled out. Although the author concluded that 
the liver damage and the asthma-like bronchitis were induced by
epichlorohydrin poisoning, a possibility remains that the liver damage had 
some other cause. Hypertension was judged to be independent of the
epichlorohydrin exposure. No renal damage was found. It is evident from 
this report [33] that irritation of eyes and throat, facial swelling, 
nausea, vomiting, headache, and dyspnea are the immediate effects of acute 
overexposure to epichlorohydrin on humans. However, it is not possible to 
draw any general conclusions on chronic effects resulting from an acute 
epichlorohydrin inhalation from this report on a single subject.
A case of a 53-year-old worker who was exposed for about 30 minutes 
to fumes of epichlorohydrin from a leaking condensor was briefly reported 
by Thoburn (written communication, May 1976). Several hours after the 
exposure, the worker complained of burning of his nose and throat, cough, 
and chest congestion. Other symptoms included running nose, eye 
tenderness, and headache followed by nausea. The man was hospitalized 
briefly. The symptoms faded within 3 to 4 days, without definite sequelae 
except that the man reported that he had more frequent infections of the
upper respiratory tract than he had experienced previously. He also
complained that these infections were often followed by productive
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after the exposure, measurements indicative of air trapping in the lungs 
(increase of residual volume by 40% and arterial p02 of 77 mm of Hg, 
instead of the normal 95 mm) were made. While the report is indicative of 
the hazards associated with acute exposures to high but unknown 
concentrations of epichlorohydrin, quantitative conclusions cannot be drawn 
from the available information.
In 1970, Ippen and Mathies [35] reported burns resulting from dermal 
contact with epichlorohydrin in five male workers, aged 19-32 years. On 
separate occasions, two workers came into contact with mixtures of 
epichlorohydrin and methanol. Two days after exposure, one worker noticed 
redness of the hands. By the 3rd day, the symptoms had intensified so 
that he went to the clinic. He had severe redness, swelling, and red 
papules on both hands. Under treatment with corticoid ointments and 
tablets of 3-pyridine methanol, a vasodilator drug, the redness and 
swelling subsided so gradually that he did not return to work until 22 days 
after the accident. More than 2 months (73 days) after the accident, he 
still had a red discoloration of the hands and erythema at the sites of the 
papules. The second worker wiped up about 1.5 liters of an 
epichlorohydrin-methanol mixture (2:3) from the floor. Even though he 
washed his hands with soap and water, he experienced redness and itching of 
the palms severe enough to require the application of corticoid ointment on 
the 4th day. He was admitted to the hospital 2 days later because of 
intensified itching of the palms and edema of the palms, fingers, and backs 
of his hands. During his 11-day hospital stay, he was treated with iv 
injections of Reparil (a saponin) and with heparinoid ointment bandages. 
The redness and swelling gradually diminished, but the skin of his hands
remained rough. The patient did not return for followup examination after 
leaving the hospital.
A third worker [35] splashed a small amount of epichlorohydrin on his 
right trouser leg. [32] He experienced a burning sensation on the thigh 
and observed a slight redness after 10 minutes. He applied a local 
anesthetic cream. Two days later, because of increased redness and
burning, he visited an outpatient clinic. On the anterior side of the 
thigh, two palm-sized and several small dark-red and extremely dry areas, 
as though tanned, were observed. The patient was treated with 
antibacterial ointments as an outpatient. The redness and burning subsided 
with only moderate residual erythema, so that he was able to return to work 
after 9 days' absence.
The two remaining incidents involved recurring exposures to 
epichlorohydrin. [35] A 19-year-old apprentice spilled epichlorohydrin on 
his shoe and stocking which he removed 6 hours later. Burning, itching,
blisters, and skin erosion developed and intensified within the next 2 
days. Severe skin erosion (5 cm in diameter) on the dorsum of the foot and 
painful, enlarged lymph nodes in the groin were evident when he was
admitted to a hospital 10 days after the accident. He was effectively 
treated with penicillin injections, moist bandages, and corticoid ointments 
and was able to return to work on the 34th day after the accident. Almost 
2 years later, he resumed work with epichlorohydrin for 3 days, during 
which he spilled the liquid on his protective rubber gloves. During the
night of the 3rd day after resuming work with epichlorohydrin, he noticed 
burning, swelling, reddening, and vesiculation on several fingers of both 
hands. He went to a clinic on the 4th day, was hospitalized for 10 days,
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and was treated with metal foil bandages and bland ointments. He returned 
to work on the 20th day following the reexposure to epichlorohydrin. In a 
followup examination 8 days later, persistent redness of the affected 
fingers was evident.
The last of the five case studies dealt with a 32-year-old worker who 
spilled epichlorohydrin in his right safety shoe. [35] Although he removed 
the shoe immediately and rinsed his foot with lukewarm water, a spotty 
redness developed within 2 hours over the ball and the base joint of the 
large toe. Physiologic saline compresses were applied for 5 days. He 
returned to work on the 6th day. Eight days later, he again spilled 
epichlorohydrin into his right shoe. Despite being aware of a slight 
burning sensation during that afternoon, he returned to work on the 
following day. On the 3d day after the accident a blister developed, and 
he went back to the hospital. After treatment with physiologic saline, and 
later with a salve of unspecified nature for 14 days, he was able to leave 
the hospital. During his hospital stay, peripheral arteriosclerosis with 
hyperlipidemia, as evidenced by 1,117 total lipids, 268 total cholesterol, 
620 mg% esterified fatty acids, and 368 mg% triglycerides, was diagnosed. 
Normal values stated in Todd-Sanford Clinical Diagnosis by Laboratory 
Methods [34] for total lipids, total cholesterol, esterified fatty acids, 
and triglycerides are 600, 250, 200, and 100 mg%, respectively. The
authors concluded that no causative relation between epichlorohydrin 
exposure and the arteriosclerosis with hyperlipidemia existed, but that the 
exposures may have had an undesirable effect on the worker's health.
Ippen and Mathies [35] referred to the skin effects from 
epichlorohydrin as protracted chemical burns and suggested several work
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practices to prevent their occurrence. They felt that specific work 
practices were necessary since epichlorohydrin penetrates rubber and 
leather. They noted that there was a latent period of several minutes to 
several hours between contact with epichlorohydrin and its manifestations. 
The authors drew attention to similar latent periods for burns caused by 
X-rays or by such alkylating agents as ethylene oxide. The authors [35] 
recommended that studies of the peripheral vasculature be done as soon as 
possible after dermal contact with epichlorohydrin to distinguish between 
sequelae and preexisting vascular alterations. This recommendation was 
made because of the persistent erythema observed after every accident and 
the pronounced peripheral arteriosclerosis diagnosed in one patient. No 
indication of sensitization was reported in the two workers whose contact 
with epichlorohydrin was repeated. These cases demonstrated that skin 
exposure to liquid epichlorohydrin can cause severe chemical burns. When 
skin contact with epichlorohydrin was short, the severity of the burns was 
much less than when skin contact was prolonged. Therefore, it can be 
concluded that the intensity of the burns is dependent on the duration and 
extent of exposure, which control the extent of reaction with cellular 
constituents.
In 1966, Pet'ko et al [11] investigated the health of workers engaged 
in the production of epichlorohydrin from dichlorhydrin glycerine (DCG) in 
Russia. Environmental monitoring for both epichlorohydrin and DCG was done 
by an unspecified sampling method. In some instances, the epichlorohydrin 
concentration in air was reported to be 2-14 times greater than its maximum 
permissible concentration. Neither the measured nor the permissible 
concentration of epichlorohydrin was reported. In the working zone of the
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workers who withdrew samples for analysis from the epichlorohydrin 
production process, the concentration range in the ambient air was 19-21 
mg/cu m or approximately 4.9-5.5 ppm. When workers poured epichlorohydrin 
into the filling tanks, the concentrations in air reached 12-15 mg/cu m 
(approximately 3.1-3.9 ppm). During an emergency due to mechanical 
difficulties, airborne epichlorohydrin concentrations of 210-211 mg/cu m 
(approximately 54.6-54.9 ppm) occurred. Forty-nine men and 33 women, 
predominately in the 20-35 age range, who worked in the epichlorohydrin 
production areas were examined. Medical examinations were directed to 
assessing the symptoms of the effects on ocular mucous membranes, the skin, 
and the respiratory, cardiovascular, and nervous systems. Morphologic 
examinations of peripheral blood, reticulocyte counts, and urinalyses were 
done. The bilirubin, cholesterol, and protein concentrations in the blood 
were also determined. Allergic manifestations of unspecified nature were 
mentioned as being present in some workers with only 2.5-3 years of service 
in the plant manufacturing epichlorohydrin. Although the authors 
considered the individual worker's length of service to be unrelated to the 
nature and frequency of the complaints, they did not report the nature of 
the complaints. They concluded that no deviations from the normal which 
could be interpreted in terms of occupational factors, other than two cases 
of occupational dermatitis, were identifiable. The dermatitis cases were 
not discussed. Pet’ko et al [11] recommended that further studies be done, 
and that annual medical examinations by an internist, a dermatologist, and 
a neuropathologist be given. The authors gave no explanation for including 
a neuropathologist, nor did they specify the clinical basis for 
recommending blood and urine examinations.
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In 1966, Fomin [28] determined the human olfactory threshold and 
subthreshold of epichlorohydrin to be 0.3 mg/cu m (approximately 0.08 ppm) 
and 0.2 mg/cu m (approximately 0.05 ppm), respectively, using an 
unspecified test method. The effects of epichlorohydrin on the light 
sensitivity of the eyes were investigated in four volunteer subjects. No 
significant ocular changes occurred with exposure to epichlorohydrin at a 
concentration range of 0.2-0.75 mg/cu m (approximately 0.05-0.19 ppm). The 
concentration of epichlorohydrin in air was determined by using an 
iodometric method based on oxidation of epichlorohydrin to formaldehyde and 
further reaction with chromotropic acid. A total of 67 
electroencephalographic (EEG) recordings were done in 5 subjects, and the 
voltage of the spikes of the alpha rhythm was analyzed quantitatively. An 
epichlorohydrin concentration of 0.3 mg/cu m (approximately 0.08 ppm), the 
olfactory threshold, caused significant (P value not given) changes In all 
five subjects. These changes included increased voltage of the spikes of 
the alpha rhythm in the EEG’s of four subjects and decreased voltage in 
that of the fifth, the latter within 10 minutes after exposure. 
Epichlorohydrin at a concentration of 0.2 mg/cu m (approximately 0.05 ppm) 
caused no changes. Unspecified conditioned reflexes were also analyzed but 
the results were not reported. Although the psychologic and physiologic 
significances of such changes in the EEG recordings are not clearly 
defined, the results do indicate that epichlorohydrin is capable of causing 
changes in the alpha rhythms of the EEG. No other reports of similar 
findings have been found in the literature.
In 1970, Fregert and Gruvberger [36] studied sensitization and cross­
sensitization of epichlorohydrin with propene oxide (propylene oxide) on
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skin. With Fregert as the subject, the authors found that, following 
application for 2 days of patches containing epichlorohydrin diluted to 
0.1, 0.5, and 1.0% with ethanol, no immediate effects on the skin were
visible, but reactions developed after 8-11 days at all test sites. 
Retesting with 0.1 and 0.01% epichlorohydrin induced a positive reaction 
after 2 days to 0.1% epichlorohydrin and resulted in erythema with 0.01% 
epichlorohydrin. Propene oxide, 0.2% in ethanol, gave a positive reaction 
when it was applied to skin previously exposed to epichlorohydrin. 
Negative reactions were obtained with 1-chloropropane (1%), l-chloro-2- 
propanol (1%), and ethylene oxide (1%) after application of these compounds 
to areas where epichlorohydrin had been applied. They concluded that the 
epoxy group and the three carbon atoms in the chain, but not the chlorine, 
were necessary for the cross-sensitization capacity. This report lacks 
experimental details and involved only one subject and, thus, is not a 
sufficient basis for a general conclusion about sensitization to 
epichlorohydrin or cross-sensitization to propene oxide.
Jirasek and Kalensky [19] examined 17 workers who developed eczema 
while working with epoxy resin. To identify the causative agent, they 
conducted dermal tests using several chemicals including epichlorohydrin. 
A 1% epichlorohydrin solution in ethanol produced positive reactions in 
three of the subjects. Experimental details were not reported.
In 1971, a summary sheet drawn by industry [37] stated that 1-hour 
exposures to epichlorohydrin at a concentration of 20 ppm induced transient 
burning of the eyes and nasal passages in manufacturing-plant workers, and 
that a similar exposure at a concentration of 40 ppm caused eye and throat 
irritation lasting 48 hours. It was further suggested that a concentration
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of 100 ppm would be intolerable for even a short period. No details of 
these exposures were given. In addition, the method by which the 
epichlorohydrin concentrations were measured or verified was not reported. 
In the absence of such information, it is reasonable to assume that these 
observations are derived from accidental occupational exposures to
epichlorohydrin.
In 1971, Wexler [38] reported similar information. At a
concentration of 20 ppm, exposure to epichlorohydrin resulted in burning of 
the eyes and nasal mucosa within 1 hour. At a concentration of 40 ppm, the 
epichlorohydrin-induced throat irritation lasted 48 hours despite immediate 
medical treatment. Wexler [38] further stated that exposure to 
epichlorohydrin at concentrations greater than 100 ppm could not be 
tolerated by humans because of the occurrence of lung edema and kidney 
lesions. Not enough detail was given to permit adequate evaluation of this 
paper. The occurrence of severe effects at 100 ppm is supported, however, 
by the previous report [37] in which it was postulated that exposure at 100 
ppm would be intolerable.
A study of 48 employees who had been exposed at least once to 
epichlorohydrin was reported by Kilian (written communication, June 1976). 
These people were studied for periods of from 7 days to 13 years after
exposure; the mean length of followup was 6.3 years. Blood samples were
analyzed for hemoglobin, albumin, globulin, cholesterol, BUN, uric acid, 
bilirubin and glucose concentrations, and alkaline phosphatase, lactic 
dehydrogenase, SGOT, and SGPT activities. Hematocrit index and total and 
differential leukocyte counts were determined also. The various values 
obtained were compared with those used by the company as normals.
The blood chemistries of two of the employees were all within the 
normal range. Overall, the most frequently observed changes involved 
differential leukocyte values. The majority of the percentage of 
polymorphonuclear leukocytes determinations were below normal for 39 
employees and above normal for 4 employees. The majority of the percentage 
of monocytes determinations were elevated for 35 employees; none had the 
greater number of the determinations below normal. Because the leukocytic 
and the monocytic changes were common to 32 of the 48 employees, it is 
reasonable to assume they are related. However, there is no proof that 
either was the result of exposure to epichlorohydrin.
A total of 16 employees had the greater number of determinations of 
percentage of eosinophilic leukocytes that were higher than normal. Total 
leukocyte counts and hemoglobin concentrations were increased in 15 
employees, while fewer total leukocytes and lower hemoglobin 
concentrations, respectively, were reported for 5 and 8 employees. With 
respect to enzyme determinations, SGOT activities were decreased in a total 
of 13 employees and increased in only 1. The other determinations rarely 
deviated from their respective normal ranges.
In the absence of further details on the extent of epichlorohydrin 
exposure and individual histories, no general conclusions can be drawn from 
these data. In the majority of the 48 cases, the deviations from normal 
ranges were no longer detectable after a few months. In five of the 
reported cases, however, one or more of the measured values remained 
outside the normal range from 7 to 13 years after exposure. Reexamination 
of one of these men about 4.5 months later gave values for the various 
measurements that were within the normal ranges.
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From the available data, it is not possible to attribute these 
persistent changes solely to epichlorohydrin exposure. The most frequently 
observed deviations from the normal ranges were a decrease in the 
percentage of polymorphonuclear leukocytes and an increase in the 
percentage of monocytes in the total leukocytes count of the blood; even 
these changes were not consistent in any employee. The data suggest that a 
detailed study of the medical histories of these individuals and their 
possible exposure to other chemicals is necessary before the hazards of 
permanent injury from epichlorohydrin exposure can be evaluated. These 
results indicate that, despite the finding of mutagenic activity for 
microorganisms in the urine of people who had been exposed to 
epichlorohydrin, there is no firm evidence that nonincapacitating exposures 
to this chemical produce persistant effects on metabolic and homeostatic 
mechanisms of the human body.
Epidemiologic Study
No published epidemiologic studies on workers exposed to 
epichlorohydrin were found. Kilian (written communication, April 1976) 
reported a retrospective morbidity study conducted on 680 DOW Chemical 
Company employees, the results of which were analyzed by an outside 
consulting firm. The medical examination data on 507 employees who had 
been exposed to epichlorohydrin for at least 6 months were presented. The 
longest term of employment was 16 years, but the majority of the people 
(exact number not given) were exposed to epichlorohydrin for periods of 5 
years or less. Environmental monitoring data were not available, but each 
employee was classified on the basis of work history and job titles as
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having either minimal or moderate exposure. A total of 110 employees were 
assigned to the moderate-exposure group and 397 to the minimal-exposure 
group. The measurements of toxic effects were: illness episodes,
electrocardiogram (ECG), X-ray examination of the chest, pulmonary function 
tests, and laboratory measurements such as urinalysis, hemograms, and blood 
chemistries. Illness, defined as absence of an employee from work for 7 or 
more days, was classified as either respiratory or nonrespiratory in 
nature. Urinalysis data included measurements of the presence of protein 
and erythrocytes in the urine. Hemograms included hematocrit index, white 
blood cell count, lymphocyte cell count, and eosinophil cell count. Blood 
chemistry included concentrations of creatinine and BUN, albumin-to- 
globulin ratio, and lactate dehydrogenase, alkaline phosphatase, serum 
glutamic oxaloacetic transaminase (SGOT), and serum glutamic pyruvic 
transaminase (SGPT) activities. An attempt was made to correlate any 
medical abnormalities with the degree of exposure.
In the minimal-exposure group, 213 employees had 1,343 episodes of 
illness (6.3 illnesses/employee), while in the moderate group 193 illness 
episodes occurred in 49 employees (4.0 illnesses/employee). Employees in 
the minimal-exposure group had 254 (39%) respiratory illnesses while
employed in the epichlorohydrin-exposure area and 231 (33%) such episodes 
while employed in other areas. In the moderate-exposure group, 57 (55%) of 
all illnesses during epichlorohydrin exposure were respiratory and only 24 
(27%) were respiratory during nonexposure to epichlorohydrin. The 
consultants concluded that illness during employment in an epichlorohydrin- 
exposure area is more likely to be respiratory than one during employment 
elsewhere.
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Examination of the ECG revealed that 5.0% of the employees in the 
minimal-exposure group and 2.7% in the moderate-exposure group had abnormal 
records. The consultants concluded that epichlorohydrin exposure had not 
influenced the ECG records.
Study of pulmonary roentgenograms indicated that, in both the 
moderate- and minimal-exposure groups, 1.8% contained abnormal findings, 
such as emphysematous blebs, mild pneumonic infiltration, pneumonia, mild 
chronic pulmonary fibrosis, minor emphysema, and infiltrative lesions. The 
consultants noted that, in addition to the same frequency of abnormal 
X-radiographs in both exposure groups, a rate of 1.8% did not appear to be 
greater than that which might be expected in similar unexposed workers. 
The urinalysis showed no clear difference between the two exposure groups 
or any group tendency toward abnormality. Hematocrit index, lymphocyte 
count, SGOT and SGPT activities, and creatinine and BUN values were within 
the normal range. White blood cell counts were above the normal limit 
during the 4th, 8th, and 12th years of employment for the moderate-exposure 
group. The mean group values for monocyte cell count were within normal 
limits except for the employees with more than 6 years of moderate 
exposure, in whom values fluctuated fairly widely around the laboratory 
normal. The difference between the average values for the two exposure 
groups was statistically significant (t value was 4.35 at a P value of less 
than 0.05) at the 3rd year. Eosinophil cell count was slightly elevated 
for the moderate-exposure group during the 2nd and 5th years of 
epichlorohydrin exposure. Lactate dehydrogenase activity was elevated in 
both groups. Examination of pulmonary function data indicated that the 
mean values for both groups did not differ from their normal values. The
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albumin-to-globulin ratio was normal for both groups, but, at the 4th year 
of exposure, the ratio for the moderate-exposure group was significantly 
lower (t value 3.88, with a P value of less than 0.05) than that of the 
minimal-exposure group. Based on all these findings, the consultants 
concluded that there were no toxic effects on the blood, liver, or kidneys 
related to the epichlorohydrin exposures.
This study, although helpful, is inadequate to fully estimate the 
health hazards associated with epichlorohydrin exposure for several 
reasons. The data base comprises a group of employees occupationally 
exposed to epichlorohydrin for periods of 6 months-16 years, but no 
consideration was given to those who dropped out because of illness, 
retirement, or death. There is no way to evaluate from this study the 
importance of the group lost from the observation. A major deficiency of 
this study is the lack of a control group. In the absence of such a group, 
the "normal" range of the clinical and the biochemical tests is dependent 
on laboratory values alone. Further, because of the lack of controls, the 
consultants compared the effects of the moderate-exposure group with those 
of the minimal-exposure group. The consultants stated that the measure of 
exposure was "a crude one" and that it was only an estimate by the company 
of whether a given individual's exposure was minimal or moderate. No 
quantitative data with regard to exposure were provided, and there is no 
indication of even what range of concentration was referred to by the 
classifications "moderate" and "minimal." Therefore, any absence of dose- 
related effects could be accounted for both by the absence of a clear 
distinction between the groups and by loss of an affected segment of 
population. From the biochemical data, it is possible to conclude that
groups of individuals "exposed" to epichlorohydrin do not show variations 
from the measured norms held to be appropriate by the laboratory. Further, 
because of the deficiencies discussed in this paragraph, the significance 
of the finding on respiratory tract illness is dubious. If the number of 
tests in any year of employment was related to the number, of employees, the 
length of employment in the moderate-exposure group was much shorter than 
in the minimal-exposure group, ie, less than half the workers were still 
employed during the 1st year and available for tests. In the minimal- 
exposure group, this point was reached in the 2nd year. The absence of 
mortality data further limits the usefulness of the study for detecting any 
chronic effects such as cancer. Animal studies [39-41] have indicated that 
epichlorohydrin induces sterility in rats; yet, reproductive histories were 
not checked. In summary, the blood chemistry and liver and kidney 
functions in groups of individuals exposed to epichlorohydrin at unknown 
concentrations were not different from the company laboratory normal 
values.
Animal Toxicity
Animal studies provide useful models to confirm and to provide 
guidance in understanding the effects of epichlorohydrin on humans. Animal 
toxicity studies with epichlorohydrin have used different species of 
animals exposed at different concentrations for different exposure periods. 
[25-27,29-31,42-49] To facilitate comparison of the data, the total amount 
of epichlorohydrin inhaled has been calculated from the concentration of 
epichlorohydrin in the inhaled air and the duration of exposure by the 
equation of MacFarland. [50] The calculated amount of inhaled
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epichlorohydrin is not equivalent to the total mass of eplchlorohydrin 
absorbed by the experimental animal or subject for two reasons. First, the 
formula is based solely on respiratory considerations and does not include 
terms for other routes of exposure, such as oral and dermal. Secondly, 
experimental evidence with other low-molecular-weight lipophilic molecules 
indicates that less than 100% of the inhaled material will be adsorbed by 
the respiratory system. [50-54] Consequently, the amount of inhaled 
epichlorohydrin may be less than or greater than the true mass of 
epichlorohydrin absorbed by the entire organism. The minute volumes used 
in this document are 1.23 liter/minute/kg in mice, 0.61 liter/minute/kg in 
rats, and 0.25 liter/minute/kg in rabbits. [56,58] If the body weight of 
animals in the studies considered in this document differed from those used 
by Guyton [57] or Crosfill and Widdicombe, [56] the minute volume was 
estimated by linear extrapolation. The absolute values obtained are likely 
to be underestimates of the minute volume since the animals used by Guyton 
[57] were either resting or recovering from anesthesia, and the animals 
used by Crosfill and Widdicombe [56] were all anesthetized. In contrast, 
the epichlorohydrin-treated animals were generally free to move about and 
hence may have had increased minute volumes. Where the actual weights of 
the experimental animals were not stated, it is assumed that the mice 
weighed 0.02 kg and the rats, 0.25 kg. It is also assumed that the animals 
were placed in the inhalation chamber after a constant concentration of 
epichlorohydrin had been reached. Based on these assumptions, these 
calculations provide a crude estimate of the relative mass of 
epichlorohydrin inhaled via the pulmonary route by the different species.
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In 1941, Freuder and Leake [25] investigated the effects of 
epichlorohydrin administered by various routes to several species of 
animals. Acute toxicity was determined by exposing white mice to 
epichlorohydrin vapor at concentrations of 2,370, 8,300, and 16,600 ppm for 
30-60 minutes. The concentrations of epichlorohydrin were estimated from 
the air flowrate and the total weight of epichlorohydrin lost from the 
container. Irritation of the nose and eyes were observed, the effects 
being more severe at higher concentrations. All 30 mice exposed at 16,600 
ppm for 30 minutes (approximately 2,315 mg/kg, inhaled amount) and all 20 
mice exposed at 8,300 ppm for 30 minutes (equivalent to 1,158 mg/kg, 
inhaled amount) died. All 30 mice exposed at 2,370 ppm of epichlorohydrin 
for 60 minutes (approximately 661 mg/kg, inhaled amount) survived.
Ten white mice were exposed to epichlorohydrin vapor at 2,370 ppm for 
60 minutes daily until all died. [25] Two animals died on the 3d day of 
administration, two more died on the 6th day, one on the 7th, two on the 
8th, one on the 9th, and the last two on the 16th day. A similar sequence 
of signs was evident in all mice exposed to epichlorohydrin. Nose and eye 
irritations were followed by gradual cyanosis, muscular relaxation of the 
extremities, stiffening of the tail, and a fine body tremor. The 
respiration decreased markedly several hours before death and ceased 
completely before cardiac arrest. Terminal clonic convulsions occurred in 
some animals.
The effect of absorption of pure epichlorohydrin through the skin was 
investigated on rats and on guinea pigs. [25] A gauze wetted with 
epichlorohydrin was applied for 1 hour to a shaved abdominal area (about 1 
sq cm) of each rat. A double layer of adhesive plastic was applied over
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the gauze to hold it in place and to reduce evaporation. Local irritation 
and discoloration developed, followed by systemic signs of epichlorohydrin 
poisoning. The doses were estimated to be 2, 1, or 0.5 cc/kg. At 2 cc/kg,
18 of 20 rats died; at 1 cc/kg, 2 of 10 rats died; and, at 0.5 cc/kg, all
10 rats survived. Six of 10 rats survived three daily dermal applications 
of epichlorohydrin at 1 cc/kg, while four applications of epichlorohydrin 
at 0.5 cc/kg killed all 10 rats. All of three guinea pigs survived single 
and repeated dermal applications up to a cumulative dose of 52
millimoles/kg (4 cc/kg) of epichlorohydrin. Evaporation was probably not 
prevented completely, and the amount of epichlorohydrin absorbed was
probably less than implied by the dose figures quoted.
Groups of 15 white mice each were also administered epichlorohydrin 
in gum arabic solution by stomach tube. [25] Epichlorohydrin at a single 
dose of 0.5 cc/kg killed all 15 mice, whereas one dose of 0.23 cc/kg 
induced no fatalities. The effects of daily oral administration of 
epichlorohydrin also were investigated in groups of 15 mice. A total of 21 
repeated administrations at 0.08 cc/kg and 4 at 0.23 cc/kg were required to 
kill all the mice in the group. The authors stated that the typical signs 
described previously were again evident. Subcutaneous injections of 0.08, 
0.16, or 0.23 cc/kg of epichlorohydrin in gum arabic solution were 
administered daily to 10 white mice until all the animals died. Daily 
administration of epichlorohydrin at a dose of 0.08 cc/kg for 21 days or at 
0.23 cc/kg for 4 days was sufficient to kill all the mice in the group. 
Thus, regardless of the route of administration (oral or subcutaneous), 
similar lethal effects were observed at equal doses.
42
A transitory fall in blood pressure without any marked effect on 
respiration was observed in three cats and in two dogs, which had been 
anesthetized with pentobarbital and given single iv injections of
epichlorohydrin at a dose of 0.1 millimole/kg (0.008 cc/kg). [27] The
minimum lethal iv dose was determined to be about 1 millimole/kg (0.08 
cc/kg) in cats and dogs. Death occurred within 2 hours of epichlorohydrin 
administration. Freuder and Leake [25] stated that deaths from exposure to 
epichlorohydrin in the animals were due to the effects on the CNS,
especially on the respiratory center. They further stated that muscular 
paralysis and gradual depression of respiration sometimes preceded the 
respiratory and cardiac failure. The authors observed no microscopic 
changes in the lungs, heart, kidneys, spleen, or bowel. This report 
indicates that epichlorohydrin presents a hazard of systemic poisoning from 
skin absorption. It is noteworthy that the authors did not examine the 
liver or observe kidney damage.
In 1949, Carpenter et al [58] reported the effect of inhalation of 
epichlorohydrin on rats as a part of a toxicity range-finding study in
which the results were given only in ranges rather than in specific 
figures. Inhalation of epichlorohydrin at 250 ppm for 4 hours killed two, 
three, or four of six rats. The authors rated epichlorohydrin as 
definitely hazardous.
In 1959, Gage [26] exposed five groups of eight albino Wistar rats 
each (four males and four females) to epichlorohydrin vapor at 120, 56, 27, 
17, and 9 ppm. Use of control animals was not reported. The vapor was 
generated by atomizing epichlorohydrin in propanol solution into a metered 
stream of air. The concentration of epichlorohydrin was calculated from
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the internal diameter of the feed syringe, the rate of piston movement, and 
the airflow. The concentration was also determined colorimetrically each 
day. All animals were exposed for 6 hours/day, 5 days/week, for 11-19 
exposures. All rats [26] inhaling epichlorohydrin at a concentration of 
120 ppm for 11 exposures (approximately 1,132 mg/kg, total amount inhaled) 
experienced labored breathing, profuse nasal discharge, a marked loss in 
weight, and leukocytosis. Urinary protein excretion was "more than double 
the normal value," which suggests damage especially to the kidneys. 
Microscopic examination of the kidneys showed areas of leukocytic 
infiltration in all rats and atrophy of the peripheral cortical tubules in 
four of the eight rats. Microscopic examination of the liver revealed 
general congestion which was accompanied in one case by areas of necrosis. 
Lung congestion, edema, consolidation, and inflamed areas with signs of 
abscess formation were also observed. Although epichlorohydrin is the most 
plausible causative agent, the absence of controls exposed to the propanol 
vehicle alone makes it difficult to attribute these changes solely to 
epichlorohydrin.
The rats exposed to epichlorohydrin at 56 ppm for 18 periods 
(approximately 864 mg/kg total amount inhaled) showed respiratory distress, 
nasal discharge, and weight loss. [28] Urinary protein excretion, 
hemoglobin concentrations in blood, and differential cell counts were 
normal. Microscopic examination showed only an abscess in one lung, which 
the author did not attribute to epichlorohydrin exposure.
Rats exposed to epichlorohydrin vapor at 27 ppm for 18 days 
(approximately 417 mg/kg total amount inhaled) showed mild nasal 
irritation. [28] The lung of one rat contained hemorrhagic and
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consolidated areas. Rats exposed to epichlorohydrin at 17 ppm for 19 
exposure periods showed no apparent effects at necropsy or on 
histopathologic examination. This exposure most likely resulted in an 
estimated inhaled amount of about 277 mg/kg. Two of eight rats developed 
pulmonary infections when exposed to epichlorohydrin at 9 ppm for 18
exposures (approximately 139 mg/kg, total amount inhaled); no effects were
observed in the other six animals.
Gage [26] also exposed two groups of two rabbits each to 
epichlorohydrin vapor. The periods of exposure were not mentioned, but 
probably, like the rats, the rabbits were exposed 6 hours/day, 5 days/week. 
The first group was exposed for 20 daily periods at 35 ppm (approximately 
439 mg/kg total amount inhaled). The second group was exposed for two
periods at 16 ppm (approximately 20 mg/kg total amount inhaled). The
latter exposure was reduced to 9 ppm and was continued for 20 more days 
(approximately 113 mg/kg total amount inhaled). Thus, the second group of 
rabbits is estimated to have inhaled a total amount of 133 mg/kg. 
Inhalation of epichlorohydrin at 35 or 16 ppm produced nasal irritation. 
At 9 ppm, no adverse effects were observed. Post-mortem examination did 
not reveal any abnormalities. Subsequent to these observations, Gage [26] 
recommended that the epichlorohydrin concentration in the occupational 
environment where employees are working continually without respiratory 
protection should not exceed 5 ppm. However, It is noted that Gage did not 
attempt to investigate any long-term effects of epichlorohydrin inhalation 
since the longest exposure lasted only 19 days. The recommendation of 5 
ppm was therefore based only on effects resulting from short-term exposure.
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In 1961, Kremneva and Tolgskaya [27] reported the effects of 
epichlorohydrin on mice, rats, and rabbits. Routes of administration were 
stomach intubation, subcutaneous injection, inhalation, and skin and eye 
application. Three groups of 10 mice and 5 rats each were administered 
aqueous solutions of epichlorohydrin by stomach tube in doses of 500, 325, 
and 250 mg/kg. All animals given doses of 500 or 325 mg/kg died within the 
first 2 days. In both rats and mice, the same type of intoxication pattern 
was evident: low mobility, slow and labored breathing, hyperemia of the
skin, subcutaneous bleeding, ataxia, periodic body tremor, and distention 
of the abdomen. Microscopic examination of tissues of the dead animals 
revealed plethora of the internal organs, hemorrhage and edema of the lungs 
and pulmonary tissue, vacuolization of the liver cells with what was 
described as fatty degeneration, and degenerative processes in the 
epithelium of the convoluted tubules accompanied by some necrosis in the 
kidneys. Foci of necrosis in the stomach and intestinal mucosa also were 
observed. At the 250-mg/kg dose, no visible signs of intoxication were 
evident during the 14-day observation period.
A total of 50 mice were injected with epichlorohydrin at doses of 
500, 375, 250, and 125 mg/kg. [29] The results of the injections were not 
described except that, at doses of 500 and 375 mg/kg, all of the mice died, 
and, at 250 mg/kg, 7 of 10 mice died. Epichlorohydrin at a dose of 125 
mg/kg was tolerated without visible alteration in the behavior of the mice.
The skin-penetrating ability of epichlorohydrin was tested when the 
tails of mice (2 groups, 10 mice each) were lowered into test tubes 
containing pure epichlorohydrin. Six of ten mice died within 3 days from a 
single 1-hour exposure. All of the 10 mice in the second group subjected
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to repeated 20-30 minute immersions died after 2 or 3 exposures. 
Morphologic examination of dead animals revealed congestion of the internal 
organs, edema, brain hemorrhage, and severe degenerative alterations or 
necrosis of the epithelium of the convoluted tubules of the kidneys. The 
authors [29] noted that the signs of intoxication in these mice were 
similar to those observed in animals injected subcutaneously with 
epichlorohydrin. Thus, the evidence indicates that epichlorohydrin can 
effectively penetrate the skin and induce severe systemic poisoning.
For inhalation exposures, 70 mice and 63 rats in groups of 10-18 each 
were placed in a 100-liter static chamber. [27] Epichlorohydrin was placed 
in the chamber and allowed to evaporate freely. Air was sampled from the 
chamber after 15-30 minutes and again 90 minutes after the start of the 2- 
hour exposure. The actual concentrations were determined by a method based 
on the reduction of chlorohydrins to chloride ions. Because of the static 
chamber, the measured concentrations at these times are not equal to either 
the average or the total exposure. Exposure to epichlorohydrin at 
concentrations ranging from 7.5 to 9.0 mg/liter (1,950-2,340 ppm) caused 
the death of all 10 animals of both species during the 1st day. There were 
no deaths in rats and mice exposed to epichlorohydrin at 0.9-1.2 mg/liter 
(approximately 234-312 ppm). Once again, it should be noted that the 
concentrations of epichlorohydrin reported give only an approximate index 
of exposure.
A group of 10 rats was exposed for 3 hours daily to epichlorohydrin 
vapor at 0.02-0.06 mg/liter (5.2-15.6 ppm) for up to 6.5 months. [27] No 
deaths or signs of intoxication were observed. The gain in body weight 
lagged behind that of the controls. The threshold of excitability of the
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nervous system increased in the exposed animals during months 2-5, but
returned to the preexposure value by the 6th month. The blood pressure of
the intoxicated animals fluctuated around a normal value of 95-100 mmHg, in 
contrast to the normal 90-95 mmHg. Oxygen consumption by the exposed
animals increased during the first 2 months but decreased after 5-6 months. 
No significant variations were observed in the composition of the 
peripheral blood. Pathomorphologic study revealed an occasional, slight 
thickening of the alveolar septa and catarrhal bronchitis. Degenerative 
alterations in the liver and kidneys were insignificant. The authors [29] 
concluded that, in rats, concentrations of 0.02-0.06 mg/liter 
(approximately 5.2-15.6 ppm) approximated the threshold. Although the
authors did not define threshold, it Is interpreted to mean the 
concentration at which no measurable adverse effect would occur in rats.
Kremneva and Tolgskaya [27] also studied the effects of 
epichlorohydrin on the mucous membranes of the eyes. A drop of 
epichlorohydrin placed into the conjunctival sac of a rabbit’s eye caused 
blepharospasm, hyperemia of the mucous membrane, lacrimation, pupillary 
constriction, reduction of the eye slit, clouding of the cornea, and edema 
of the lids. Recovery occurred within 10 days. The persistent skin damage 
following dermal contact with epichlorohydrin seen in humans [35] is 
confirmed by these animal studies. The suggestion of Kremneva and 
Tolgskaya [27] that measures be taken to provide skin and eye protection to 
avoid damage is supported by others. [11,19,25,35,37]
Based on these extensive studies, Kremneva and Tolgskaya [27] 
suggested 0.001 mg/liter (approximately 0.26 ppm) as a tentative maximum 
permissible concentration of epichlorohydrin in the occupational
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environment. Bartlett [59] reported the pulmonary ventilation rate as a 
function of the degree of the metabolic activity which ranged from sleep to 
maximum work. A ventilation rate of 25 liters/minute or 1.5 cu m/hour is 
intermediate between light and medium work. Consequently, this ventilation 
rate is an estimation of a spectrum of work activities in the manufacture, 
use, and handling of epichlorohydrin. For an individual working 10
hours/day with a ventilation rate of 25 liters/minute or 1.5 cu m/hour, the 
approximate amount inhaled during an 8-hour workday would be 0.21 mg/kg for 
a 70-kg man.
In 1967, Pallade et al [29] found the subcutaneous LD50 of
epichlorohydrin in rats to be 150 mg/kg. An 8% epichlorohydrin solution in 
propylene glycol was used and the animals were observed for 2 weeks. 
Application of 0.5 ml of epichlorohydrin to the skin of an unspecified 
number of rabbits for 24 hours caused a lesion with a central zone of 
coagulation necrosis surrounded by one of a hard edema involving the 
superficial layer of the dermis. A zone of erythema with punctiform
hemorrhages extending beyond the area of contact with epichlorohydrin 
appeared at the periphery. In all cases, the areas of necrosis and 
erythema became covered with a bloody fibrinous scab after 2-3 days that 
persisted for up to 30 days. Application of 0.1-0.2 ml of epichlorohydrin 
for 24 hours caused similar, but less severe and smaller, lesions. The 
authors reported that all rabbits on both application schedules recovered.
Effects of epichlorohydrin [29] by the cutaneous route were
determined by immersing the tails of 10 mice for 15-20 minutes in test 
tubep containing undiluted epichlorohydrin. [29] Seven of the mice died, 
and the three survivors showed local lesions leading to the loss of the
49
distal portion of the tail.
Effects on the kidneys were studied in 57 rats divided into four 
groups. Epichlorohydrin was administered by an unspecified route in single 
doses of 180, 150, 125, and 100 mg/kg. [29] The animals were placed in
metabolism cages for a period of 2 weeks. Daily urine outputs were
examined for albumin concentration and sediment. Methods of analysis were
not reported. At 100 mg/kg, 22 of 27 rats (81.5%) had oliguria, and one
(3.7%) had anuria. Anuria was observed at 125 mg/kg in 7 of 12 rats,
(58.3%) and, at 150 mg/kg, in 10 of 12 rats (83.3%). Following the
administration of epichlorohydrin at 125 or 150 mg/kg, the rest of the 
animals had oliguria. At a dose of 180 mg/kg all six (100%) animals had 
anuria. Mortality rate was 66.7% for animals receiving 180 or 150 mg/kg 
epichlorohydrin. Mortality rates were 50 and 7.4%, respectively, in the 
125 mg/kg and the 100 mg/kg groups.
Epichlorohydrin at a single dose of 150 mg/kg was injected by an 
unspecified route into 80 rats. [29] Blood catalase (Enzyme Commission 
Number, E.C. 1.11.1.6) and carbonic anhydrase (E.C. 4.2.1.1) activities 
were determined in 55 and 25 animals, respectively, on days 1, 3, 5, 7, 9,
and 16 after injection. Blood catalase and carbonic anhydrase activities 
were measured in 26 and 12 untreated control rats, respectively. The 
catalase activity of the treated animals at the end of the 16-day period
showed a statistically significant decrease of 20% (P value equal to or
less than 0.05) In contrast to the 2.5% decrease observed in control rats. 
Decreases in carbonic anhydrase activity of about 10% also were observed in 
the treated animals. The long duration of these effects on enzyme 
activities is noteworthy, and, as the authors pointed out, this persistence
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suggests irreversible, and perhaps cumulative, changes.
For microscopic studies, [29] 23 rats were treated with
epichlorohydrin at 150 mg/kg, and 14 rats were treated at 180 mg/kg. A 
similar, or probably the same, study was reported in greater detail in 
Rumania by Rotaru and Pallade, [30] who reported administering 150 or 180 
mg/kg of epichlorohydrin by single subcutaneous injections to 23 and 14 
albino rats, respectively. Tissues from animals killed at 24 or 48 hours, 
or 5 or 10 days after the injection and from those which expired during the 
experiment were examined microscopically. Immediately after death, samples 
from the myocardium, lungs, liver, kidneys, spleen, stomach, intestine, 
adrenals, and brain were taken for study. The induced effects were similar 
at both doses, but were more severe at the higher dose. The kidneys were 
the most damaged organs. Animals examined at 24 hours showed ischemia of 
the cortex and congestion of the deep cortical layers near the medulla. 
Various degrees of congestion and interstitial edema with hemorrhagic foci 
also were present in the medulla. In all cases, prevailing lesions of 
degenerative or necrotic nature were evident in all nephrons but were 
especially severe in the proximal parts of the nephrons. Diffuse, cloudy 
intumescences, granular alterations, granular vacuoles, and homogeneous 
eosinophilic coagulation also were observed. The authors attributed these 
observations to a marked cellular metabolic Imbalance. The epithelium was 
severely affected and showed nuclear damage, as evidenced by karyolysis, 
karyorrhexis, and karyopyknosis. This damage was attributed by the authors 
to the irreversible nature of the degenerative lesions which became 
necrotic. Examination of the tubular basal membranes revealed that, in 
some cases, they were discontinuous for various lengths, and that
disruptive cortical lesions were especially prevalent. Minimal 
perinecrotic inflammatory infiltrates appeared 48 hours after treatment at 
both doses. On the 5th day, epithelia with hypertrophic nuclei in the 
necrotic zones and occasional binuclear regeneration were present. On the 
10th day, most of the tubules consisted of regenerated epithelium, and the 
ischemic necrotic zones were no longer recognizable. In general, the gross 
and microscopic tissue damage detected during the first 48 hours was no 
longer present, despite the persistence of changes in the activity of blood 
enzymes. The signs observed in the animals as a result of epichlorohydrin 
exposure appear to be those caused by a general systemic poison. The 
authors concluded that epichlorohydrin had a marked primary nephrotoxic 
action complicated by its action on the vascular system. They further 
concluded that regeneration could reestablish the structural integrity of 
nephrons in the surviving animals. However, the evidence is insufficient 
to conclude that the functional activity of the nephrons was fully 
restored.
Examination of other organs revealed generalized damage. [30] 
Alveolar septal congestion, desquamative bronchial catarrh, and sporadic 
edema of the peribronchovascular connective tissue were detected in the 
lungs. The spleen exhibited frequent areas of sludged blood and small 
hemorrhagic foci. The stomach and intestine showed occasional slight 
congestion and edema in the mucosa with eventual desquamative catarrh. The 
liver and heart exhibited no appreciable microscopic alterations, and only 
a slight degree of congestion was present in the brain and adrenal glands.
In 1967, Soloimskaya [42] reported the effects of single subcutaneous 
injections of 125, 250, or 500 mg/kg of epichlorohydrin in 112 rats. For
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controls, 93 untreated animals were used. Two days later, the blood of the 
rats injected with epichlorohydrin was examined for pyruvic acid, 
oxalacetic acid, and total citric and isocitrlc acids. Free aromatic 
amines were determined for animals treated at all three doses. At 250 
mg/kg, increases in pyruvic acid, total citric and isocitric acids were 
observed, and at all three doses, increases in the free aromatic amine 
concentrations occurred in the blood. The concentration of oxalacetic acid 
in the blood decreased in animals given 250 mg/kg. Elevated concentrations 
of pyruvic acid and total citric and isocitric acids in the blood indicate 
altered rates of metabolism. After grinding the liver and incubating the 
mixture for 3 hours, its histaminase activity (E.C. 1.4.3.6) was
determined. The average histaminase activity of the liver in 10 control 
animals was 130 ± 1.84 ¡ig/g. Animals injected with a dose of 500 mg/kg of 
epichlorohydrin had a sharp decrease in histaminase activity to 42 ± 0.54
jug/g and those injected with epichlorohydrin at a dose of 250 mg/kg had a 
decrease to 83 + 2.43 ¿tg/g. In animals injected at a dose of 125 mg/kg, 
there was a decrease to 98 ± 1.56 pg/g. Thus, compared with the control 
animals, the rats at all three doses had sharply decreased histaminase 
activity in the liver. Although there is no evidence of decrease in 
histaminase activity in humans exposed to epichlorohydrin, the decrease in 
histaminase activity could be of clinical significance, particularly in 
people susceptible to allergies and sensitization. Other reports on the 
effects of epichlorohydrin on histaminase activity have not been found.
In 1972, Lawrence et al [31] reported on a series of experiments 
intended to determine acute and subacute effects of epichlorohydrin. The 
oral and ip LD50's for epichlorohydrin were determined by using unspecified
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numbers of mice, rats, guinea pigs, and rabbits. The animals were observed 
for 7 days after epichlorohydrin administration. The ip LD50 ranged from 
0.10 to 0.14 ml/kg for mice, rats, guinea pigs, and rabbits, while the oral 
LD50 was 0.20 ml/kg for mice and 0.22 ml/kg for rats. The dermal LD50 was 
0.64 ml/kg for rabbits. Inhalation of epichlorohydrin vapor by mice 
resulted in an LT50 of 9.13 minutes at 71.89 mg/liter (18,690 ppm). The
concentrations were not verified by analytical techniques. However, it
should be noted that the animals were probably exposed to epichlorohydrin 
at an increasing concentration up to 71.89 mg/liter (18,690 ppm).
Tissue culture experiments were performed by the agar-overlay method 
with mouse fibroblasts. [31] Epichlorohydrin in cottonseed oil was applied 
to paper disks which were placed on the surface of the agar and incubated 
at 37 C for 24 hours. A cytotoxic response had occurred when a clear zone 
of lysed cells surrounded the disk. Epichlorohydrin at 0.00122% v/v 
(0.00016 M) was cytotoxic to the cells, but, at 0.000486% v/v (0.000062 M)
or less, no effects were observed. The hemolytic activity of
epichlorohydrin was evaluated by estimating the amount of hemoglobin 
released by addition of 0.2 ml of oxalated whole rabbit blood to 10 ml of 
various saline solutions of epichlorohydrin. When the epichlorohydrin 
concentration was 0.01 M, hemolysis was first detected; when it was 0.0375 
M, 50% hemolysis occurred. In the absence of further experimental details, 
it is not possible to draw conclusions about the dose-response relationship 
for epichlorohydrin-induced hemolysis.
To assess the irritant effects on eyes, 0.1 ml of epichlorohydrin 
solution in cottonseed oil was instilled into the right eyes of the 
rabbits; the left eyes served as the untreated controls. [31] The eyes
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were examined every 30 minutes for 3 hours. Corneal damage was present in 
80% of the animals and a lesser degree of irritation occurred in the rest 
of the animals. Epichlorohydrin was found to be a strong ophthalmic 
irritant.
There was no evidence of sensitization to epichlorohydrin, as 
determined by the maximization test in 5 Hartley-strain guinea pigs. [31] 
Groups of 12 male Sprague-Dawley rats were injected ip daily for 30 
consecutive days with 0.00955 or 0.01910 ml/kg of epichlorohydrin or 
0.01910 ml/kg of cottonseed oil. At the end of 30 days, hemoglobin values 
were increased significantly at the low dose but decreased significantly at 
the higher dose (P values less than or equal to 0.05). The concentration 
of neutrophilic metamyelocytes increased significantly (P value less than 
or equal to 0.05) in the high-dose group but remained equal to that of 
controls for the rats administered epichlorohydrin at the lower dose. 
Lymphocytes showed an insignificant dose-related decrease in frequency. A 
slight, insignificant dose-related increase in clotting time was also 
observed. Hepatic function, as measured by the BSP test, was not impaired. 
The heart-to-body weight ratio increased in a dose-related way but the 
increases were not statistically significant. The ratio of the weight of 
the kidney to body weight increased significantly with both doses (P value 
less than or equal to 0.05). The ratio of brain-to-body weight of the rats 
was higher in the epichlorohydrin-treated rats than in the controls. 
Microscopic examination did not reveal changes in any organs except in the 
lungs. Lesions in the lungs were evident in all groups, but the incidence 
and severity were "somewhat greater" in the treated animals than in the 
controls. It is noteworthy that the authors did not detect any kidney
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damage in the microscopic examination.
Lawrence et al [31] also investigated the effect of administering 
epichlorohydrin ip to rats on Mondays, Wednesdays, and Fridays for 12 
weeks. Four groups of male Sprague-Dawley rats received either 0.04774 
ml/kg of cottonseed oil (control) or 0.0095, 0.0190, or 0.04774 ml/kg
(1/10, 1/5, and 1/2 the ip LD50) of epichlorohydrin in cottonseed oil. The 
number of animals in each group was not specified. A significant reduction 
(P value less than or equal to 0.01) in the body weight gain accompanied by 
reduced food intake was seen in the group receiving epichlorohydrin at the 
highest dose. A dose-related (the higher the dose, the greater the
reduction) and statistically significant (P less than or equal to 0.05) 
decrease in hemoglobin was observed. All animals treated with 
epichlorohydrin had lower hematocrit and erythrocyte counts than the
control rats, but this was significant (P value less than or equal to 0.05)
only for the hematocrit value of the middle-dose group. An increase in the 
concentration of platelets in the blood also was observed in the
epichlorohydrin-treated animals. Total leukocyte counts were lower in the 
low-dose group and higher in the highest-dose group than in the control 
group. These differences were not significant (P value less than or equal 
to 0.05). Leukocyte counts for the middle-dose and control groups were the 
same. A dose-related increase in the average percentage of segmented 
neutrophils was observed but was significant (P value less than or equal to 
0.01) only for the high-dose group. The percentage of eosinophils 
increased in all experimental groups, the increases in the low- and the 
high-dose groups being significant (P value less than or equal to 0.05). 
Significant reductions in the percentage of lymphocyte in the total
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leukocyte count were observed in the animals treated with the two highest 
doses (P values less than or equal to 0.05 and 0.01, respectively). The 
ratio of the weight of the brain to that of the body was significantly 
lower (P value less than or equal to 0.01) in the animals treated with 
epichlorohydrin at the highest dose than in the control animals; this is in 
contrast to the effect obtained in animals receiving 30 daily doses of 
epichlorohydrin. The change in the brain-to-body weight ratio suggests
abnormal changes in the CNS. The organ weight-to-body weight ratios for
heart, kidneys, and liver were significantly (P values less than or equal 
to 0.01, 0.01, and 0.05) higher for the animals treated with the highest 
dose than for the controls. The ratio of spleen-to-body weight was not 
significantly different from that found in the controls. The results 
indicate that repeated doses induce a cumulative effect on basic cellular 
growth with a subsequent perturbation of the normal rates of growth of 
these internal organs.
The effect of epichlorohydrin on pentobarbital-induced sleeping time 
was studied in mice. [31] Male ICR-strain mice in groups of 10 were 
administered 1/10, 1/5, or 1/2 of the acute ip LD50 dose (0.14 ml/kg) of
epichlorohydrin. Control mice were administered ip saline injections. 
Similar groups of mice were exposed to epichlorohydrin vapor at 1/10, 1/5,
or 1/2 of the LT50 dose (71.89 mg/liter, 9.13 minutes). Control mice were
placed in an inhalation chamber and were exposed to uncontaminated air. 
Twenty-four hours after exposure to epichlorohydrin by either route, 50 
mg/kg of sodium pentobarbital was administered ip. A dose-related increase 
in sleeping time was observed in all the epichlorohydrin-treated animals; 
however, the only significant increases (P value less than or equal to
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0.01) were in the groups receiving the highest ip dose or the highest 
inhalation exposure. Based on these extensive studies, it can be concluded
that epichlorohydrin is severely irritating to the skin and the eyes, and
perhaps to the lungs. Further, it also affects some metabolic processes of 
the liver. In most cases, the severity of its effects appears to be dose 
dependent.
In 1972, Lawrence and Autian [44] further examined the effect of 
epichlorohydrin on pentobarbital-induced sleeping time. Groups of 10 male 
ICR mice were exposed to epichlorohydrin vapor at 98.20 mg/liter
(approximately 25,500 ppm) for 0.92, 1.83, or 4.58 minutes daily for 3 days 
(0.1, 0.2, or 0.5 times the inhalation LT50). Based on the assumptions
discussed at the beginning of this section, the approximate amounts inhaled 
were 333, 663, and 1,600 mg/kg, respectively. Pentobarbital-induced
sleeping time was measured 24 hours after the last exposure. Compared with 
that of the control animals, an increased sleeping time was apparent in the 
test rats, suggesting an effect on microsomal processing enzyme systems of 
the liver.
Fomin [28] exposed three groups of 15 male albino rats to 
epichlorohydrin vapor for periods of 24 hours/day for 98 days at 20 ±
0.026, 2 ± 0.007, or 0.2 ± 0.001 mg/cu m. These concentrations approximate 
5.2 ± 0.01, 0.5 ± 0.002, or 0.05 ± 0.0003 ppm and the total amounts inhaled 
are estimated to be 1,722, 172, or 17 mg/kg, respectively. Epichlorohydrin 
concentrations were determined colorimetrically. A fourth group of 15 
animals served as a control. Peripheral blood was sampled for analysis of 
fluorescence of leukocytes from five rats in every group, at first once a 
week and then once every 2 weeks. Compared with the controls, animals
receiving epichlorohydrin at the highest dose had a sevenfold increase in 
the number of leukocytes with altered fluorescence. The nucleic acid 
concentration in the blood of the same animals decreased to 90.73 mg% in 
contrast to 127.07 mg% in the control group. An increase in the amount of 
urinary coproporphyrin, 2.68 /xg compared with 1.07 jug in the control group, 
occurred in the animals receiving epichlorohydrin at the highest dose. 
Reduced weight gains and prolonged latent periods of the motor defense 
reaction were also observed in this group of animals. Gross and 
microscopic examinations disclosed emphysema, bronchopneumonia, edematous 
areas, and loosening and swelling of the adventitia of blood vessels in the 
lungs. Cloudy swelling of the epithelium of the convoluted tubules in the 
kidneys and foci of interstitial hemorrhage and venous congestion in the 
heart were evident. Severe lesions of the neurons in the medulla 
oblongata, Ammon's horn, and cerebellum were also present.
Animals inhaling epichlorohydrin at 0.5 ppm showed an increase in
leukocytes with altered fluorescence, a decrease in the nucleic acid
content of the blood, but no significant effects on the amount of urinary 
coproporphyrin. [28] The concentration of leukocytes with altered 
fluorescence increased significantly (95% probability of not being a
variation by chance), but the effect was less marked than on the animals 
treated at the highest dose. Animals in the third group, inhaling 
epichlorohydrin at 0.05 ppm, did not show similar effects. There were no 
morphologic differences between the control animals and those in the last 
two groups.
Based on the results of this continuous inhalation study, Fomin [28] 
recommended that the mean diurnal maximum permissible concentration of
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epichlorohydrin in the atmosphere not exceed 0.2 mg/cu m (approximately 
0.05 ppm). The exposure in this study was continuous and the effect of 
intermittent recovery periods was not evaluated.
In 1969, Golubev [45] recorded changes in the diameters of the pupils 
of the eyes of rabbits. Groups of six rabbits were used to ascertain the 
irritating effects of eight different chemicals, including epichlorohydrin. 
The rabbits' eyes were illuminated with a uniform reflected light, and the 
diameters of the pupils were measured with an instrument referred to as a 
tangential pupilometer. A 0.25 M solution of epichlorohydrin was instilled 
into the conjunctival sacs and the pupil diameters were measured 1, 3, 5, 
10, 15, 20, 25, and 30 minutes later. In the control rabbits, the pupil 
diameters were measured both before instillation and at similar time 
intervals after instillation of 0.05 ml of saline solution into the 
conjunctival sacs. Epichlorohydrin caused constriction ranging from 1 to 
16% during the first 20 minutes, the initial diameter being considered 
100%. The author noted that this effect was elicited at an epichlorohydrin 
concentration that caused no visible changes in the conjunctivae or cornea. 
Thus, epichlorohydrin at 0.25 M (2.3%) has a measurable effect on the eyes.
In 1968, Pallade et al [46] subcutaneously injected 67 white rats 
with a single dose of epichlorohydrin at 125 mg/kg to investigate 
epichlorohydrin-induced kidney damage. Prior to injection, the urine of 
each animal was examined for protein, potassium, and sodium; thus, each 
animal served as its own control. The animals were kept in metabolism 
cages; their urines were examined 1, 2, 3, and 8 days after epichlorohydrin 
administration. Oliguria or anuria was exhibited by 53 (79%) animals and 
polyuria by 4 (6%). The remaining 10 (15%) produced urine at normal rates.
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Of the 53 rats that produced little or no urine during the period 
immediately after the administration of epichlorohydrin, 7 (13.2%) entered 
a stage of polyuria within 2-3 days after the administration of the dose. 
The mortality rate was 13.4%, death occurring only among the oliguric and 
anuric animals. Urinary protein was determined by spectrophotometry and 
urinary potassium and sodium were measured by flame photometry. Although 
it was evident in all animals, proteinuria was more marked in the oliguric 
animals. The excretion of protein in the urine returned to normal after 8 
days. Sodium concentration in the urine was low and remained so even after 
8 days; the potassium concentration was elevated initially but returned to 
normal within 8 days.
Serum was examined 48 hours after epichlorohydrin was administered to 
60 rats. [46] Protein concentrations were determined by a modified 
Weichselbaum method, sodium and potassium by flame photometry, and serum 
lipids by microphotometry. Reductions in serum protein and sodium 
concentrations and an elevation in the serum potassium concentration were 
observed. The concentrations of total serum lipids and the lipase activity 
of serum were not different from those in 40 untreated rats serving as 
controls.
Pallade et al [46] noted that proteinuria and the parallel oliguric 
and anuric conditions indicated the occurrence of renal damage. If tissue 
repair and regeneration had occurred, the animals survived. They concluded 
that the signs of renal disorders confirmed that epichlorohydrin is 
nephrotoxic to rats. Therefore, medical examinations oriented to the 
detection of renal disorders were recommended for workers exposed to 
epichlorohydrin.
In 1966, Shumskaya and Karamzina [47] used epichlorohydrin as a known 
nephrotoxin to evaluate various measures of kidney function in rats. Since
the intent of these investigations was not to identify epichlorohydrin
toxicity, details such as time of exposure and number of animals used were 
generally not specified. Polyuria, secretion of urine of low specific
gravity, proteinuria, reduced urinary chloride concentrations, and 
increased concentrations of nitrogen-containing substances in the urine 
were found.
In 1971, Shumskaya et al [32] conducted another study similar to the 
one discussed in the previous paragraph. [47] Experiments with single 4- 
hour inhalations of epichlorohydrin at 0.35 mg/liter (91 ppm), at 0.02 
mg/liter (5.2 ppm), and at 0.007 mg/liter (1.8 ppm) were conducted on three 
groups of 60 male white rats each; the control group comprised 60 rats. 
Information on how epichlorohydrin vapor was generated and information on 
the size of the chamber were not provided. Neither was it indicated
whether the chamber was operated in the static or the dynamic mode. The 
total amounts of epichlorohydrin inhaled during each of the 4-hour exposure 
periods are estimated to have been approximately 51, 2.9, and 1.0 mg/kg, 
respectively. The same effects seen in the previous experiment [47] were 
observed. In addition, the weights of the liver and kidneys were 
increased, whereas those of the lungs and the spleen were decreased. 
Removal of BSP from blood was decreased on the day of exposure, but not 
reliably on the day after the exposure. The production of urine was 
increased by all three levels of exposure, with concomitant decreases in 
the specific gravity of the urine. The daily output of chlorides in the 
urine on the day after exposure was usually increased by a larger factor
than the production of urine. The daily excretion of protein in the urine 
was also increased, but less than that of chlorides. No additional studies 
of pulmonary and splenic function were reported. Reductions in both oxygen 
consumption and body temperature also were observed. A significant (P 
value not given) stimulating influence on the mobility of spermatozoa also 
occurred in animals exposed to epichlorohydrin at the two lower
concentrations. Even though the intent of these experiments was to
evaluate various tests as indices of intoxication, important information on
the toxicity of epichlorohydrin was generated. The results are summarized
in Table XIII-2. They demonstrate that even short-term exposure to 
epichlorohydrin at approximately 1.8 ppm induces perturbations in basic 
physiologic processes such as consumption of oxygen and regulation of body 
temperature in mammals. These experiments [32,47] suggest that
epichlorohydrin affects the function of the liver, as indicated by the BSP
tests, and the kidney, as indicated by the production of urine and the 
reabsorption and filtration of chloride and protein. Lungs and spleen were 
also affected, but no assessment of the impacts on the functions of these 
organs was made. The authors concluded that epichlorohydrin affects the 
kidneys, liver, lungs, and nervous system.
Since a number of enzymes are involved in reabsorption and tubular
secretion In the kidneys, Pallade et al [48] investigated the effects of 
epichlorohydrin on the activity of several enzymes. White rats of both 
sexes were administered epichlorohydrin subcutaneously at single doses of 
125 mg/kg dissolved in propylene glycol. Animals were killed 2.5 or 24 
hours after the administration of the dose and examined for various enzyme 
activities in the urine, renal tissue, and serum. Cytochrome oxidase (E.C.
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1.9.3.1), succinic dehydrogenase (E.C. 1.3.99.1), and carbonic anhydrase 
(E.C. 4.2.1.1) activities were determined by manometric methods. Alkaline
phosphatase (E.C. 3.1.3.1) activity was determined by the Gomori method, 
the transaminases activity by a colorimetric method, and catalase (E.C. 
1.11.1.6) activity by an iodometric method.
Renal cytochrome oxidase activity was determined in 14 rats and in 10
controls 24 hours after they had been injected with epichlorohydrin. [48]
Statistically significant (P value less than or equal to 0.01) inhibitions 
were observed in treated animals. Renal succinic dehydrogenase activity, 
determined 24 hours after epichlorohydrin administration, was similar for 
10 experimental and 6 control animals. Examination of 40 treated and 30 
control rats showed reductions in renal carbonic anhydrase activity of 6- 
11% 24 hours after the administration of epichlorohydrin. This reduction 
was not statistically significant. Glutamic-pyruvic transaminase (GPT)
(E.C. 2.6.1.2) activity was measured 2.5 and 24 hours after administration 
in both renal tissue and serum. There were 30 animals in the group
examined at 2.5 hours after epichlorohydrin administration and 40 in the 
group examined 24 hours postdose. At 2.5 hours, no change was observed in 
the kidneys, but a statistically significant (P value less than or equal to 
0.01) increase in SGPT activity was observed at both the 2.5-hour and the 
24-hour intervals. A significant reduction (P value less than or equal to 
0.01) was observed at 24 hours; there were 0.230 units of activity in the 
controls in contrast to 0.100 units in the experimental group. The average 
SGPT activity in the experimental group ranged from 0.051 ± 0.022 units at 
2.5 hours to 0.058 ± 0.018 units at 24 hours, in contrast to the control 
group average of 0.034 ± 0.010 units. Glutamic-oxaloacetic transaminase
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(GOT; E.C. 2.6.1.1) activities in the kidney were similar for the controls 
and the intoxicated animals at 2.5 hours, but significantly (P values less 
than or equal to 0.01) different at 24 hours in the experimental rats 
(0.261 ± 0.046 units) versus 0.302 ± 0.040 units in the controls. SGOT
activity was significantly increased in the experimental rats, 0.045 ±
0.009 units at 2.5 hours (P value less than or equal to 0.02) and 0.046 ± 
0.010 units at 24 hours, (P value less than or equal to 0.01) in contrast 
to 0.040 ± 0.008 units observed in the controls. Alkaline phosphatase
activity was assayed in 30 experimental animals and in 30 controls. The 
animals given epichlorohydrin showed a significant reduction (P value less 
than or equal to 0.01) in the mean kidney phosphatase activities (0.029 ±
0.008 units) at 2.5 hours but had a mean alkaline phosphatase activity 
comparable with that in the controls (0.033 ± 0.014 units) at 24 hours. 
However, serum alkaline phosphatase activity decreased progressively at 
both 2.5 and 24 hours. Catalase (E.C. 1.11.1.6) activity was measured in 
the kidneys and in the urine of 20 treated and 20 control animals. Renal 
catalase activity was only 3.93 ± 1.86 units in the experimental animals, 
whereas it was 7.91 ± 2.67 units in the controls. The average of urinary 
catalase activity of the epichlorohydrin-treated animals was about nine 
times that of the controls.
Pallade et al [48] stated that the observed changes in serum, urine, 
and kidney enzyme activities resulted from renal lesions or were 
consequences of general toxic effects in other tissues. In view of the 
reports on the nephrotoxicity of epichlorohydrin, [32,46,47] it seems 
likely that the altered serum enzyme activities may be due to renal 
lesions. As the authors [48] noted, however, damage to such other tissues
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as liver and heart also can cause elevated blood enzyme activities. This 
study does not rule out the possibility that such effects are involved in 
the genesis of the observed changes in the enzymes of serum. In addition, 
direct chemical inhibition of enzyme-active centers or alteration of the 
rates of production or degradation of the enzyme could have caused the 
effects noted, but this was not discussed or evaluated by the authors. In 
particular, catalase, an enzyme participating in cellular oxidation- 
reduction reactions, is distributed widely in renal and hepatic cells and 
in erythrocytes. The reduced renal catalase activity observed may be 
attributed to renal damage, but, as the authors pointed out, the observed 
increase in urinary catalase activity could have been due to the presence 
of erythrocytes, leukocytes, or bacterial contamination as well as to 
leakage from damaged renal epithelial cells. Increases in serum 
transaminase activities (SGOT and SGPT), accompanied by reductions in these 
activities in the kidneys of experimental animals, were attributed by the 
authors to cellular lesions or to changes in mitochondrial permeability 
which precede cell destruction. The results of this study clearly indicate 
that exposure to epichlorohydrin induces major changes in several basic 
biochemical functions of the kidneys in laboratory mammals. The observed 
increase in urinary catalase activity suggests that examination of this 
activity may be a useful test to monitor for acute overexposure to 
epichlorohydrin in humans.
Grigorowa et al [60] determined the LC50 of epichlorohydrin in albino 
rats weighing 230-270 g and in albino mice weighing 18-26 g. Groups of 20 
animals of each species were exposed to epichlorohydrin at concentrations 
of 0.190, 0.390, 0.855, 0.915, or 1.680 mg/liter (49.4, 101.4, 222.3,
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237.9, or 436.8 ppm, respectively) for 4 hours in the case of the rats and 
for 2 hours in the case of the mice. One-half the animals in each group 
were subsequently exposed for 45 minutes to an environmental temperature of 
35 C and a relative humidity of 35-50%. Survivors were counted 7 2 hours 
after exposure. The exposure to heat had no appreciable effect on the 
LC50. The values with and without heat were 2.2 and 2.4 mg/liter (582 and 
635 ppm) for rats and 4.0 and 3.0 mg/liter (1,060 and 793 ppm) for mice.
Grigorowa et al [60] further exposed 2 groups of 60 male albino rats 
weighing 230-270 g to epichlorohydrin at concentrations of 0.6 or 0.06 
mg/liter for 4 hours/day for 8 days. An additional group of 60 rats served 
as controls. One-half the animals in each group had a 45-minute exposure 
to an environmental temperature of 35 C and a relative humidity of 35-50% 
after each epichlorohydrin exposure; the other half received no temperature 
stress. Ten rats in each subgroup were killed on days 2, 4, or 11 of the 
experiment. Exposure at 35 C for 45 minutes on each of 8 days within an 
11-day period had no effect on body weight. Inhalation exposure at a 
concentration of 0.6 mg/liter of epichlorohydrin for 4 hours/day for eight 
times during 11 days decreased body weight by about 9%. Combination of 
these two exposures, that to heat following immediately after that to 
epichlorohydrin, had the same effect on body weight as exposure to the 
chemical alone. This finding agrees with that relating to the LC50. In 
conclusion, the amount of heat stress had no effect on these two responses 
of rodents to epichlorohydrin.
Despite these two negative findings, there were a few instances in 
which addition of heat stress seemed to modify toxic actions by the 
chemical stressor. Thus, rats exposed to both heat and epichlorohydrin
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were reported to have had somewhat less marked alterations of the structure 
of the liver and the thyroid follicles, but more pronounced ones of the 
adrenal medulla, than those exposed to epichlorohydrin alone. Five rats 
showed moderate accumulations, resembling abscesses in some instances, of 
leukocytes around blood vessels in the interstitial tissue of the thyroid. 
The animals tended to have increased relative weights of lungs, liver, 
kidneys, and adrenals (though not for each organ at all times of slaughter) 
and increased whole blood catalase (E.C. 1.11.1.6) and serum lactate
dehydrogenase (E.C. 1.1.1.27) activities. Urinary volume and protein
concentration decreased; changes in serum sodium, potassium, and leucine 
aminopeptidase (E.C. 3.4.1.1) were inconsistent. At the 0.06 mg/liter 
epichlorohydrin exposure, fewer effects from the addition of heat stress 
were observed and consisted principally of increases in the whole-blood 
catalase and serum leucine aminopeptidase activities. Therefore, exposure 
to an elevated environmental temperature sometimes altered some effects of 
epichlorohydrin exposure, most notably increasing the blood-catalase 
activity.
Effects on Reproduction
Epichlorohydrin-induced sterility has been reported in animals. [39— 
41] Cooper et al [39] administered epichlorohydrin suspended in arachis 
oil orally to adult male Wistar rats. No controls were used. Five daily 
doses of 20 mg/kg (a total of 100 mg/kg), or of 50 mg/kg (a total of 250 
mg/kg), or a single dose of 100 mg/kg were given to five animals at each 
level. Animals receiving 5 daily doses of 20 mg/kg lost fertility during 
the first 2 weeks, but completely regained it by the third week. The
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fertility of these rats was tested for 10 weeks. The sperm cycle in rats 
is 8 weeks. Rats receiving the five 50 mg/kg of epichlorohydrin doses were 
rendered completely sterile throughout a 10-week period. Microscopic 
examinations of reproductive tissues were done weekly for 20 consecutive 
weeks after the 100 mg/kg dose. Sterility occurred within the 1st week 
after treatment with epichlorohydrin at a dose of 100 mg/kg. Fertility 
returned during the 2d week, but the average litter size was reduced by 
about one-third. By 12 weeks, probable permanent sterility had occurred. 
Apart from small spermatoceles in the efferent ductules of the testes, 
histologic examination revealed no abnormalities up to 8 weeks after the 
administration of epichlorohydrin at a dose of 100 mg/kg. However, by 12 
weeks, large retention cysts were present in the efferent ductules and the 
proximal caput in four of five sterile animals. Therefore, when the 100 
mg/kg dose is administered in five equal daily doses, a reversible 
functional sterility occurs, while at a single dose of 100 mg/kg, 
spermatoceles form and permanent sterility may result.
Jones et al [40] investigated the antifertility effects of 
epichlorohydrin on Wistar rats. A single oral or ip administration of 
epichlorohydrin at a dose of 50 mg/kg in an aqueous solution produced 
"antifertility effects resembling those due to alpha-chlorhydrin." Details 
about measurement of antifertility, duration of the sterility, the time 
between dosage and onset of sterility, and the number of animals used were 
not reported.
In 1970, Hahn [41] gave daily oral doses of 15 mg/kg of 
epichlorohydrin for 12 days (a total of 180 mg/kg) to adult male rats of 
demonstrated fertility. Control animals were also observed. Two preestrus
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female rats were placed in the cage of each male at different times during 
the study. After 7 days, the fertility of each male was evaluated on the 
basis of the number of uterin6 implantations in the females. Within 1 
week, the males became infertile, but fertility was restored within the 
next week. On the 12th day, histologic examination of the testes, 
epididymis, prostate, and seminal vesicles showed no differences between 
the experimental and the control animals. The number of experimental 
animals was not reported. The kinetics of the effect cannot be evaluated 
since sterility observed at week 1 could have occurred on the 1st or the 
7th day. Thus, the inference may be made that the sterility induced in 
male rats by epichlorohydrin is dose and time dependent. [39,41]
In 1972, Epstein et al [61] reported the effects of epichlorohydrin
on the rate of pregnancy in ICR/Ha Swiss mice in a dominant lethal assay.
A dose of 150 mg/kg of epichlorohydrin was administered to 10 male mice by
ip injection. Each male was then caged with three undosed virgin female
mice for 1 week. The females were replaced each week for 8 weeks and then 
killed and examined for pregnancy. The numbers of total live implants, 
early fetal deaths, and late fetal deaths were recorded. Since, in 
general, late fetal deaths were exceedingly rare, total implants and early 
fetal deaths were the only features of pregnancy analyzed. The authors did 
not report the observation of any effects of epichlorohydrin on early fetal 
deaths or other reproductive characteristics, including male fertility. 
Therefore, it can be concluded that epichlorohydrin at 150 mg/kg given to 
male mice in a single ip injection does not increase the ratio of early 
fetal deaths to the total number of implantations occurring in the uterus 
of the female mice to which they are mated.
A summary of the results of the animal studies, other than for 
carcinogenicity and mutagenicity, is presented in Table III-l.
Carcinogenicity
In 1963, Kotin and Falk [62] reported at a conference, and Falk 
confirmed in a written communication of September 1975, that skin 
papillomas and cancer of the lymphatic system and of the lungs were 
observed in C3H strain mice injected with epichlorohydrin. A dose of 5 
in 0.1 ml of ethyl laurate or tricaprylin was administered in a single 
subcutaneous injection to each of 30 mice, which were then observed for 
about 2 years. Control animals were injected with either solvent. Four 
experimental animals developed malignant lymphomas at 3.25, 3.25, 5.5, and 
6 months after the beginning of the experiment. The incidence of lymphomas 
in the control group was about half that observed in the experimental 
animals. In the mice injected with epichlorohydrin, there was a sl^ in 
papilloma after 11.5 months, a hepatoma in another mouse after 13 months, 
and 2 lung adenomas in 1 mouse after 24 months. The control animals had 
occasional hepatomas and lung adenomas, but no skin papillomas. The 
survival of the epichlorohydrin-treated animals was poor. During the 1st 
year, 12 mice died; after the 2nd year, only a few survived. Falk noted 
that, except for the single skin papilloma, the tumors were generally of 
the same type and frequency of occurrence as in the control groups. Thus, 
the experiment was inconclusive.
In 1963, Weil et al [63] reported the results of a skin carcinogenic 
assay with 60 epoxy compounds, including epichlorohydrin, on 90-day-old 
C3H-strain mice. Hair was removed from the backs of about 40 mice and
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undiluted liquid epichlorohydrin was painted onto the midline 3 times/week 
for 25 months. The amount of epichlorohydrin applied was not measured. At 
the end of 12 months, 37 mice survived; at the end of 17 months, 30 were 
alive; and, at the end of 24 months, only 1 survived. Examinations showed 
no tumors and no signs of toxicity. Based on the mortality rate, the 
authors stated that epichlorohydrin was the most toxic of the epoxides 
tested. The only control substance was methylcholanthrene, a positive 
control, which induced tumors. Thus, it can be concluded that, under the 
conditions of this experiment, dermally applied epichlorohydrin does not 
induce significant numbers of skin tumors in C3H-strain mice.
In 1974, Van Duuren et al [64] reported the final results of dermal 
application, subcutaneous injection, and ip injection of epichlorohydrin on 
female ICR/Ha Swiss mice. Previously, Van Duuren had published two papers 
reporting preliminary [65] and intermediate results. [66] Since the 
complete report is now available, [64] the earlier papers are not discussed 
in this document. In the skin-application experiments, 50 mice were shaved 
initially and whenever necessary during the experiment. A dose of 2.0 mg 
of epichlorohydrin in 0.1 ml of acetone was applied three times/week to the 
interscapular region. The test lasted for 580 days (83 weeks). Skin 
lesions were diagnosed as papillomas when they reached 1 cu mm in size and 
persisted for 30 days or more. No papillomas or carcinomas occurred in the 
animals to which epichlorohydrin, acetone, or nothing was applied.
A group of female ICR/Ha mice had 2.0 mg of epichlorohydrin in 0.1 ml 
of acetone applied to the skin followed 2 weeks later by three applications 
each week, and throughout the study (total duration, 385 days), of 2.5 jug
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of phorbol myristate acetate (PMA), a promoter, in 0.1 ml of acetone. [65] 
In the group of 50 mice to which epichlorohydrin was applied, nine mice 
developed papillomas and one a carcinoma. Control animals to which solvent 
(30) alone or no chemical (100) was applied produced no tumors. Of the 
mice to which PMA alone (30) was applied, three developed papillomas.
For an assay by subcutaneous injection, 50 mice were injected weekly 
in the left flank with 1.0 mg of epichlorohydrin in 0.05 ml of tricaprylin. 
[64] This test also lasted for 580 days. Of the animals given 
epichlorohydrin, six developed sarcomas and one an adenocarcinoma (P value 
less than or equal to 0.05). In comparison, 1 mouse of 50 injected with 
tricaprylin alone developed sarcoma, and none of the control animals 
developed any tumors. The significance of subcutaneous sarcomas which 
occur at the injection site has been discussed by Grasso and Golberg. [49] 
In an ip assay, 30 mice received weekly injections into the lower abdomen 
of 1.0 mg of epichlorohydrin in 0.05 ml of tricaprylin. The experiment was 
terminated after 450 days. None of the mice developed local sarcomas, but 
11 had papillary lung tumors. Of mice given tricaprylin alone, 10 had 
papillary tumors of the lungs and 1 developed a local sarcoma.
The results of these studies raise concern about an additional risk 
of carcinogenesis for the segment of human population continuously exposed 
to epichlorohydrin throughout the working lifetime. Available experimental 
evidence [67] indicates that the risk of induction of cancer in animals and 
in humans can be reduced by reducing the maximum allowed cumulative dose to 
which they are exposed. Based on these reports, further tests involving 
long-term inhalation exposures of animals to epichlorohydrin must be done 
to determine the degree of occupational risk following chronic inhalation
73
of epichlorohydrin. A tabular summary of results of the carcinogenic 
studies is presented in Table III-2.
Mutagenicity
Definitions of various terms used in this section are given in the 
Glossary, Appendix IV. [68,69]
One of the earliest mutagenicity studies was undertaken by Rapoport 
[70] who, in 1948, reported that epichlorohydrin induced 0.7% mutations (4 
mutations in a total of 526 chromosomes) in Drosophila melanogaster. A 
control series showed no mutations (0 mutations in 887 chromosomes). 
Although lack of details about the experimental design prevents a thorough 
evaluation of this report, it provides evidence that epichlorohydrin 
induces mutations in this eukaryotic organism.
In 1951, Loveless [71] defined radiomimetic activity as a highly 
specific effect upon the resting cell producing an alteration in the 
genetic material. He postulated that this alteration can be shown by 
chromosome breakage and rearrangement in subsequent divisions. Root tip 
meristems of Vicia faba (broad bean) were treated with epichlorohydrin 
solutions of unspecified concentrations. Exposure was limited to 1 hour, 
and epichlorohydrin at a wide series of concentrations was tested. At 4-6 
hours after treatment, samples were examined for immediate effects on those 
cells already in division at the time of treatment and again at 18, 24, 36, 
or 48 hours to determine the effect upon cells in the resting stage at the 
time of treatment. The author [71] rated epichlorohydrin as having a "low 
activity" but did not state what was meant by this term; he indicated that 
the results of this study would be discussed fully in a later paper.
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However, such a report has not been found.
The induction of mutations in microorganisms has been used as an 
ancillary method to study genetic responses to environmental agents. [72] 
Microbiologic assays offer a number of unique experimental advantages over 
mammalian assays. They can use large populations so that they have the 
capacity to detect events which occur infrequently. Also, microbial test 
systems are available which can distinguish between mechanistically 
different classes of microscopic mutations (base-pair substitution and 
frameshift mutations) and macroscopic alterations (chromosomal 
translocations and deletions). All these genetic alterations have been 
observed in human populations. [7,72] However, routine mammalian 
mutagenicity test systems which are capable of detecting base-pair 
substitutions and frameshift mutations in the offspring of mammals are not 
simple or very practical. From a practical viewpoint, microbial assays are 
rapid and relatively inexpensive. With the exception of certain viruses, 
the genetic material of all organisms consists of deoxyribonucleic acid, 
often complexed with ribonucleic acid and protein. [72] It is, therefore, 
clear that evidence of mutation induced by a chemical in microbial systems 
is a cause for concern for human populations but does not provide a basis 
for establishing the degree of risk to human populations.
In 1955, Kolmark and Giles [73] studied the induction of mutations by 
epichlorohydrin and five other monoepoxides. A purple mutant of Neurospora 
crassa lacking adenine, strain 38701, was used for the induction of 
reverse mutation. The spontaneous mutation rate at the loci governing 
adenine independence for Neurospora crassa is 0.0008-0.029 
mutations/100,000 gametes. [69] Epichlorohydrin at a concentration of 0.15
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M was added directly to a suspension of macroconidia in sterile distilled 
water. The suspension was kept at 25 C and gently agitated for 15-60 
minutes, centrifuged, and then washed. At various intervals, portions were 
then plated onto a minimal agar medium. Controls were treated similarly 
except that no epichlorohydrin was added to the suspension. The number of 
viable, surviving conidia was determined by plating diluted samples on 
minimal medium supplemented with adenine. Out of a million surviving 
conidia, 8.5 reverse mutations were induced when treated with 
epichlorohydrin for 15 minutes. When the treatment was for 60 minutes, All 
mutations/million surviving conidia were induced. Thus, under the optimal 
conditions of 0.15 M epichlorohydrin for a 45-minute exposure, 7.36 x 10*7 
(* means "to the power of") conidia were treated and yielded 4,140 
revertants. The background was 39 revertants; the survival was 41.5%. 
This yields an average value of 135.2 induced premutational lesions/million 
surviving conidia, or 20 premutational lesions/mole of 
epichlorohydrin/minute. The biochemical nature of the original mutations 
in the conidia that were reversed by epichlorohydrin was not discussed. 
This test gives an underestimate of the true back-mutation frequency at 
this locus, since macroconidia were tested, and, if each such conidium 
contained three nuclei, a reversion in more than one nucleus would still be 
scored as a single revertant.
In 1960, Strauss and Okubo [74] reported the mutagenic actions of 
ultraviolet radiation and alkylating agents. One of the alkylating agents 
selected was epichlorohydrin. A tryptophan-requiring mutant of Escherichia 
coli, strain B/r, was used. The measure of mutation was the change from 
tryptophan requirement to independence, a reverse mutation. The number of
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revertants present in a particular sample was determined by plating a 0.1- 
ml portion of the bacterial suspension on plates of minimal medium on a 
tryptophan-free nutrient agar. The total number of viable cells was 
determined by plating after dilution on nutrient agar containing 
tryptophan. The cells from overnight cultures were collected, washed twice 
with 0.1 M phosphate buffer of pH 7.2, and suspended in the same buffer at 
approximately 7 x 10*8 cells/ml. Epichlorohydrin (2 ml) was suspended in 3 
ml of ethanol, but it did not go completely into solution. One milliliter 
of this mixture was added to 100 ml of the bacterial suspension and 1-ml 
portions were removed and plated without being washed. Cells were plated 
on either minimal agar or minimal agar supplemented with a small amount of 
nutrient broth to allow several divisions of the cells to enhance the 
expression of the revertant phenotype. Cells were also harvested, washed 
to remove excess epichlorohydrin, and resuspended in the buffer before 
plating. In the control, there were 2.2 x 10*8 viable cells plated. A 
total of 6.4 revertants/10*8 cells plated on the minimal medium and 11.4 
revertants/10*8 cells plated on the minimal medium containing the nutrient 
broth were observed. When cells were harvested immediately after the 
addition of epichlorohydrin, there were 1.7 x 10*8 viable cells plated. 
Cells plated on the minimal medium showed 0.3 revertants/10*8 cells. Cells 
plated on the medium containing the broth showed 28.0/10*8 revertants. 
When cells were incubated with epichlorohydrin for 15 minutes before 
harvesting, there were 1.5 x 10*8 viable cells plated. There were no 
revertants in the cells plated on the medium alone and 38.3/10*8 revertants 
in cells plated on the medium containing the broth. Thus, the revertants 
are calculated to have increased at the rate of 30 premutational
lesions/mole of epichlorohydrin/minute during the 60-minute treatment. 
Survival was approximately 80% at the end of the treatment.
In 1973, Mukai and Hawryluk [75] reported testing epichlorohydrin in 
Escherichia coli and in Salmonella typhimurium. Since the details of the 
tests were not given, Mukai (written communication, October 1975) reported 
that 11.8 mg of epichlorohydrin in 0.1 ml of dimethyl sulfoxide was applied 
to sterile filter paper disks and placed in the center of duplicate test 
plates. Base-pair substitutions in Escherichia coli and both base-pair 
substitutions and frameshift mutations in Salmonella typhimurium were 
induced by epichlorohydrin. He further reported that greater than 
twentyfold increases in revertants over control plates were observed in 
both organisms.
In 1973, Voogd [76] reported in an abstract testing several epoxy 
compounds, including epichlorohydrin, for their abilities to Induce 
mutations in a Klebsiella pneumoniae auxotroph requiring uracil and proline 
for growth. Mutations to streptomycin resistance were scored. The author 
stated that nearly all the tested substances displayed a certain degree of 
mutagenicity and that the mutagenic activity of the epoxy group was often 
slightly increased by electrophilic groups on carbon atoms next to the 
epoxy group. Voogd provided additional information in a written 
communication of October 1975. Increases in mutations in both Klebsiella 
pneumoniae and Salmonella typhimurium were induced by epichlorohydrin. The 
experiment was a Luria-Delbruck fluctuation test, [77] so that a true 
mutation rate, and not a mutation frequency, was measured. In the
Klebsiella pneumoniae assay, the mutation frequency was based on a forward 
mutation to streptomycin-resistance or streptomycin-dependence. In
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general, such mutations alter a ribosomal protein, and chemicals which 
cause frameshift mutations or lead to deletions are not detected as
mutagens in such an assay. The cells were suspended in broth in a
concentration of 100 cells/ml, and 105 samples of 2.5 ml were treated for
20 hours with 0.00637 M epichlorohydrin. After treatment with 
epichlorohydrin, the maximum reported frequency of mutations was 7.617/10*9 
or 45.A times the background of 0.1676/10*9. In the Salmonella assay, his 
G-46, TA1530, TA1535, TA100, and TA98 strains were also tested for
mutagenesis by a procedure similar to the Klebsiella assay. The first four 
strains contain the same base-pair substitution mutation. The reverse 
mutation to histidine-independence was increased in all four strains by 
0.001 M epichlorohydrin. Strain TA98 contains a frameshift mutation and 
did not revert when treated with epichlorohydrin.
Recently, workers exposed to epichlorohydrin were monitored for the
presence of mutagens in their urine (DJ Kilian, written communication,
April 1976). The study group included six people exposed to
epichlorohydrin at concentrations from 0.8 to 4.0 ppm, measured as 8-hour
TWA concentrations, and two people exposed by a large epichlorohydrin spill
that generated a concentration in air in excess of 25 ppm. Five subjects
who had not been exposed to epichlorohydrin served as controls. Mutagenic
activity was evaluated using Salmonella typhimurium strains 1535, 1537,
1538, 100, and 98. Results are summarized in Table XIII-3. All samples
except the two from individuals with high exposures were comparable with
those from the control subjects; preparations derived from the urine of
these two individuals indicated the presence of materials which influenced
the genetic mechanism of Salmonella typhimurium. With the 1535 strain, an 
%
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increase in mutants in excess of twofold over the control was evident. In 
strain 1537, a statistically significant decrease in the number of mutants, 
relative to the controls, was observed. Although there were only six 
people in the data base, this report does indicate that exposure to high 
concentrations of epichlorohydrin may give positive results. While it is 
not possible to draw any dose-effect relationship from this small group of 
subjects, the results of the study tend to indicate that a genetically 
active material is present within the human body after a sufficiently large 
exposure to epichlorohydrin.
In summary, the induction of reverse mutations by epichlorohydrin in 
N crassa, [73] E coli, [74] and S typhimurium, [75] and forward mutations 
in K pneumoniae [76] have been observed. Most of the microbial mutations 
could be accounted for by base-pair substitutions. Following exposure to 
epichlorohydrin, mutations have occurred in the fruit fly (Drosophila 
melanogaster). [70] Thus, apparently epichlorohydrin can induce point 
mutations in some organisms, both prokaryotic and eukaryotic. Other than 
the dominant lethal assay, [61] reports of experiments designed to detect 
epichlorohydrin-induced inheritable genetic alterations in mammals have not 
been found, so that a reasonable basis for estimating the risk to the human 
population has not been established. However, it has been shown that a 
substance that can induce mutations is present in the urine of people who 
are overexposed to epichlorohydrin (DJ Kilian, written communication, April 
1976). The results of the mutagenicity experiments discussed in this 
section are summarized in Table III-3.
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Correlation of Exposure and Effect
Occupational exposure to epichlorohydrin occurs chiefly by inhalation 
and skin contact and, to a limited extent, by ingestion. Cases of delayed 
skin burns resulting from contact with epichlorohydrin in the occupational 
environment have been reported. [35] Burning, itching, blisters, skin 
erosion, redness, and residual erythema have been the usual signs. 
Usually, there has been a latent period of a few minutes to several hours 
between the dermal contact and the resulting effects. The severity of the 
bums has been dependent upon the duration of the contact. One worker who 
failed to remove his epichlorohydrin-contaminated shoes for 6 hours 
developed severe skin damage with painful, enlarged lymph nodes in the 
groin; he was hospitalized for 22 days. Another worker who washed his 
hands with soap and water after wiping up an epichlorohydrin-methanol 
mixture from the floor developed itching, burning, redness, and swelling, 
and was hospitalized for 11 days. Edema, ulceration, hyperemia, and 
necrosis of rabbit skin resulting from dermal application of 
epichlorohydrin also have been observed. [27,29] Kremneva and Tolgskaya
[27] reported also that, when the tails of 10 mice were immersed for an 
hour in test tubes containing epichlorohydrin, 6 animals died within 3 
days.
Thus, experience in both humans [35] and animals [27,29] indicates 
that epichlorohydrin may induce, in addition to severe damage to the skin, 
systemic poisoning following dermal absorption. The intensity of these 
effects appears to increase with the dose and the duration of exposure.
There are very few reports of the effects on humans of 
epichlorohydrin inhalation. [11,33,37,38] One report [33] involved a
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worker who was acutely exposed to epichlorohydrin at an unspecified but 
probably very high concentration. Eye and throat irritation, nausea, 
vomiting, headache, and dyspnea were the immediate effects. Bronchitis, 
liver damage, and hypertension were detected during the 2 years following 
the accident. An industrial report [37] stated that exposure to 
epichlorohydrin at 100 ppm, even for a short period, would be intolerable 
to humans. This was based on the observation that exposure to 
epichlorohydrin at 40 ppm for an hour caused eye and throat irritation 
lasting 48 hours and that exposure at 20 ppm for one hour caused temporary 
burning of the eye and nasal passages. Wexler [38] reported that exposure 
to epichlorohydrin at concentrations greater than 100 ppm induced lung 
edema and kidney lesions in humans. Pet'ko et al [11] observed changes in 
the reticulocyte count, bilirubin, cholesterol, and protein concentration 
of the blood in people occupationally exposed to epichlorohydrin. These 
changes were not statistically significant. An epidemiologic study (DJ 
Kilian, written communication, April 1976) of workers exposed to 
epichlorohydrin revealed no abnormalities. Because of the lack of a 
control group, lack of information on the exposure concentrations, and 
because the longest exposure period was only 16 years, it is difficult to 
make any final conclusions regarding chronic effects, especially those with 
long latent periods.
Fomin [28] reported that inhalation of epichlorohydrin at 0.08 ppm 
induced statistically significant (P value not given) changes in the EEG 
recordings in all of five volunteers; no effects were observed at a 
concentration of 0.05 ppm. Since the exposure period was not given, it is 
not possible to estimate the dose of epichlorohydrin absorbed. If the
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concentrations stated in this paper are correct, it can be concluded from 
this study that inhalation of epichlorohydrin at 0.08 ppm induces 
measurable effects on brain function in humans.
Epichlorohydrin-induced sterility in animals has been reported. 
[39,41] Cooper et al [39] found that 12 repeated doses of epichlorohydrin
at 100 mg/kg caused an apparently permanent sterility of male rats as
indicated during a 12-week period, while Hahn [41] found that the dose of 
15 mg/kg/day of epichlorohydrin produced a reversible sterility. It can be 
concluded that, in rats, epichlorohydrin causes sterility which is both 
dose and time dependent. The induction of sterility following repeated 
doses of 15 mg/kg is another example of the time-dependent cumulative 
nature of effects induced by epichlorohydrin. The results from the 
experiments in mice and rats are insufficient to permit any inference of 
the rate at which epichlorohydrin must be absorbed to induce inheritable 
genetic alterations in the offspring of mammals, although the evidence 
suggests that epichlorohydrin may influence the spontaneous mutation rate 
in mammals.
Animal studies in which inhalation was the principal route of entry 
have been extensively reported. [26-28] Gage [26] found that labored 
breathing, profuse nasal discharge, loss of weight, leukocytosis, increased 
urinary protein concentration, and peripheral atrophy of the cortical 
tubules in the kidney occurred in rats exposed to epichlorohydrin at 120 
ppm. Respiratory distress, nasal discharge, and weight loss were evident 
in rats inhaling epichlorohydrin at 56 ppm; these effects were still
present but less severe at 27 ppm. No effects were observed on rats
exposed to epichlorohydrin at 17 ppm; however, at 9 ppm, pulmonary
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infection occurred in two rats. Fomin [28] reported increases -in 
leukocytes with altered fluorescence and urinary coproporphyrin, 
accompanied by decreases in the nucleic acid content of the blood, in rats 
exposed to epichlorohydrin at 5 ppm; in addition, lung and kidney damage 
were present. Some of these effects were also present in rats exposed to 
epichlorohdyrin at 0.5 ppm, while none were observed at 0.05 ppm. Kidney 
damage and disrupted liver function were observed in animals exposed at 5.2 
and 1.8 ppm. [32] From these studies, it can be concluded that 
epichlorohydrin causes liver and kidney damage in animals. There are two 
conditions of exposure at which epichlorohydrin induced no effects: 27
ppm, 6 hours/day, for 18 days [26] and 0.05 ppm, 24 hours/day, for 98 days.
[28]
Carcinogenicity, Mutagenicity, and Teratogenicity
Van Duuren et al [64] have reported that epichlorohydrin induces 
tumors in mice at subcutaneous injection sites when administered alone. 
Weil et al [63] and Van Duuren et al [64] found that epichlorohydrin 
induced no tumors in mice by skin painting assay. The data of the skin 
applications followed by a promotor suggest that epichlorohydrin may 
initiate the carcinogenic process in mice. [64] Weekly ip injections of 
1.0 mg epichlorohydrin resulted in 11 of 30 mice developing papillary lung 
tumors, which was similar to the observations in the control group.
The induction of mutations following exposure to epichlorohydrin in 
microbial species has been reported. [71,73,75] The experiments indicate 
that epichlorohydrin can induce base-pair substitution mutations. It is 
evident that epichlorohydrin induces a high frequency of mutations in
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fungi, [71] microbial organisms, [73-76] and in the fruit fly. [70] The 
most plausible molecular basis of the epichlorohydrin-induced mutations in 
all of these organisms is the covalent bonding of epichlorohydrin to the 
cellular genetic material, DNA. In view of the virtual irreversibility of 
these reactions, the degree of genetic damage may be expected to increase 
with exposure time in these lower organisms as well as in higher forms. 
[78]
Reports of experimental attempts to induce the formation of terata by 
exposing pregnant female animals to epichlorohydrin have not been found.
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TABLE III-l
EFFECTS OF EPICHLOROHYDRIN IN ANIMALS
Routes of 
Exposure Animals No.
Exposure 
Concentration 
and Duration
Ref-
Effects erence
Inhalation Mice 30 16,600 ppm 
30 min
Nose and eye irritation, 
mortality 100%
25
tl II 20 8,300 ppm 
30 min
Mortality 100% 25
ft ft 10 2,370 ppm 
1 hr/d 
x 16 d
If 25
It ft 30 2,370 ppm 
1 hr
No deaths 25
tt Rats 6 250 ppm 
4 hr
Death of 2-4 rats 58
ft tt 8 120 ppm 
6 hr/d 
5 d/wk 
x 11 d
Labored breathing, pro­
fuse nasal discharge, 
weight loss, leukocytosis 
increased urinary protein 
peripheral atrophy of 
cortical tubules
26
9
9
tl it 60 91.0 ppm 
4 hr
Kidney damage, liver 
function disrupted
32
tt ti 60 5.2 ppm 
4 hr
ft 32
tt tt 60 1.8 ppm 
4 hr
Kidney damage and dis­
rupted liver function 
less severe than with 
91.0 and 5.2 ppm
32
If tt 8 56 ppm 
6 hr/d 
5 d/wk
Respiratory distress, 
nasal discharge, weight 
loss
26
x 18 d
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TABLE III-l (CONTINUED)
EFFECTS OF EPICHLOROHYDRIN IN ANIMALS
Routes of 
Exposure Animals No.
Exposure 
Concentration 
and Duration Effects
Ref­
erence
Inhalation Rats 8 27 ppm 
6 hr/d 
5 d/wk 
x 18 d
Mild nasal irritation 26
11 i t 8 17 ppm 
6 hr/d 
5 d/wk 
x 19 d
No effects 26
t t M 8 9 ppm 
6 hr/d 
5 d/wk 
x 18 d
Pulmonary infection 26
I t i i 15 5.2 ppm 
24 hr/d 
x 98 d
More leukocytes with 
altered fluorescence, 
increased urine copro­
porphyrin, kidney and 
lung damage, decrease 
in blood nucleic acid
28
t f n 15 0.5 ppm 
24 hr/d 
x 98 d
Increased modified 
leukocytes, reduced 
blood nucleic acid
28
11 i i 15 0.05 ppm 
24 hr/d 
x 98 d
No effect 28
Sub­
cutaneous
i i 120 500 mg/kg 
250 mg/kg 
125 mg/kg
Reduced blood histamine 
activity
42
I t i i 14 180 mg/kg Necrotic lesions in 
nephrons; nonspecific 
lung, brain, and 
adrenal gland damage
30
t t i i 23 150 mg/kg 
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TABLE III-l (CONTINUED)
EFFECTS OF EPICHLOROHYDRIN IN ANIMALS
Routes of
Exposure Animals No.
Exposure 
Concentration 
and Duration Effects
Ref­
erence
Sub­
cutaneous
Oral
Rats
67
Mice 10
10
15 
15
15 
15
Rats
Dermal Rabbits
Rats 20
10
10
150 mg/kg
125 mg/kg
0.23 ml/kg/d 
x 4 d
0.08 ml/kg/d 
x 21 d
0.5 ml/kg
0.23 ml/kg/d 
x 4 d
0.23 ml/kg
0.20 ml/kg
0.08 ml/kg/d 
x 21 d
0.22 ml/kg
0.64 ml/kg
2 ml/kg 
x 1 hr
1 ml/kg 
x 1 hr 
x 3
1 ml/kg 
x 1 hr
LD50
Oliguria, anuria, poly­
uria, kidney damage
Mortality 100%
No deaths 
LD50
Mortality 100%
LD50
LD50
Mortality 80%, local 
irritation
Mortality 40%, local 
irritation
Mortality 20%, local 
irritation
29
46
25
25
25
25
25
31
25
31
31
25
25
25
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TABLE III-l (CONTINUED)
EFFECTS OF EPICHLOROHYDRIN IN ANIMALS
Routes of
Exposure Animals No.
Exposure 
Concentration 
and Duration
Ref-
Effects erence
Dermal Rats 10 0.5 ml/kg 
x 1 hr 
x 4
Mortality 100%, local 
irritation
25
f f f f 10 0.5 ml/kg 
x 1 hr
Local irritation, no 
deaths
25
iv Cats - 0.08 ml/kg Minimum lethal dose 25
f t I f 3 0.008 ml/kg Transitory fall in blood 
pressure
25
I I Dogs - 0.08 ml/kg Minimum lethal dose 25
I I f t 2 0.008 ml/kg Transitory fall in blood 
pressure
25
ip Mice, rats, 
guinea pigs 
and rabbits
9
0.10 to 
0.14 ml/kg
LD50 31
89
TABLE III-2
CARCINOGENIC EFFECTS OF EPICHLOROHYDRIN IN MICE
Routes of 
Exposure Strain No.
Exposure 
Concentration 
and Duration Effects
Ref­
erence
Sub­
cutaneous
C3H 30 5 /¿M 4 malignant lymphomas, 
(about double the 
control value)
Falk*
I I ICR/Ha
Swiss
50 F 1 mg** 
1/wk 
x 83 wk
1 adenocarcinoma, 
6 sarcomas
64
Controls It 50 F vehicle
only
1 sarcoma
ip t t 30 F 1 mg** 
1/wk 
x 64 wk
11 papillary lung tumors 64
Controls I t 30 vehicle
only
10 papillomas 
1 sarcoma
Painting 
on clipped 
backs
C3H 27 - 
30
Undiluted 
3/wk 
x 25 mon
0 tumors 63
Application 
to shaved 
backs
ICR/Ha
Swiss
50 F 2.0 mg in " 
0.1 ml acetone 
3/wk 
x 83 wk
64
II II 30 F 2.0 mg in 
0.1 ml 
acetone***
9 papillomas, 
1 carcinoma
64
I t t l 30 F controls**** 3 papillomas
*(H Falk, written communication, September 1975)
**Dissolved in 0.05 ml tricaprylin
***Beginning 2 weeks after the one epichlorohydrin application, 2.5 ng of 
PMA was applied three times/week for 53 weeks.
****2.5 ¿ig of PMA only was applied three times/week for 53 weeks.
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TABLE III-3
MUTAGENICITY STUDIES
Species Dose Results Reference
Drosophila
melanogaster
Unspecified Epichlorohydrin-induced 
mutations, 0.7%; none in 
control series
70
Neurospora
crassa
0.15 M Epichlorohydrin-induced 
premutational lesions, 
20/mole/minute, over the 
background
73
Escherichia
coli
0.017 M Epichlorohydrin-induced 
(reverse) premutational 
lesions, 30/mole/minute, 
over the background
74
Escherichia
coli
1.27 M in 
dimethyl- 
sulfoxide
A 20-fold increase in 
revertants over control
75
Salmonella
typhimurium
II fl 75
Klebsiella
pneumoniae
0.00637 M A 45.4-fold increase in 
mutations over background
76
Salmonella
typhimurium
0.001 M An increased number of 
induced mutations over 
control
76
91
IV. ENVIRONMENTAL DATA AND ENGINEERING CONTROLS
Environmental Data
Dow Chemical Company [2] reported personnel monitoring data by job 
classification for its units which produce allyl chloride, epoxy resin, and 
glycerine. Sampling was conducted with charcoal tubes using a calibrated, 
battery-operated pump. Quintuplicate samples were taken for each job 
classification at a rate of 2 liters/minute for 7 hours. Epichlorohydrin 
and chlorinated hydrocarbons were extracted with 30 ml of carbon disulfide. 
Epichlorohydrin recovery from the charcoal, after sampling, was found to be 
65%. Analysis was performed with a hydrogen flame chromatograph equipped 
with a 12 feet x 1/8 inch column packed with 15% Oronite NiW on gas chrom 
CLA (60-80 mesh). In 1973, in the epoxy resin unit, one air sample in the 
breathing zone of each of four employees (three operators and one helper) 
showed the average epichlorohydrin concentration to be 0.03 ppm. In the 
same year, 78 grab samples indicated that epichlorohydrin concentrations 
ranged from 13 ppm to less than 0.60 ppm, with an average of 3.17 ppm. It 
should be noted that the "average" was a numerical average between the 
individual samples,- not the TWA concentrations. The results of air 
monitoring done in 1974 are presented in Table IV-1. In the glycerine 
distribution unit, five air samples in the breathing zones of an operator, 
two for the head operator, and two for the technician showed 
epichlorohydrin concentration to be below 0.01 ppm. These were taken in 
1975. Results of air monitoring for epichlorohydrin done in the glycerine 
plant in 1975 are presented in Table IV-2. Epichlorohydrin concentrations 
in the allyl chloride unit were below 0.1 ppm.
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TABLE IV-1
EPICHLOROHYDRIN CONCENTRATIONS IN THE AIR IN 
AN EPOXY-PRODUCING UNIT (1974)
Job No. Epichlorohydrin
Classification Samples (ppm v/v)
High Low Average
Warehouse operator 4 0.30 0.30 0.30
Machinist 1 0.10 0.10 0.10
Pipefitter 2 0.30 0.30 0.30
Control C operator 3 0.90 0.40 0.66
2d class operator BIS 1 0.10 0.10 0.10
Grab samples 25 15.00 0.60 2.02
Stationary monitoring 23 1.00 0.10 0.26
From reference 2
TABLE IV-2
EPICHLOROHYDRIN CONCENTRATIONS IN THE AIR IN 
A GLYCERINE-PRODUCING UNIT (1975)
Job No. Epichlorohydrin
Classification Samples (ppm v/v)
High Low Average
Control "A" 5 1.37 0.24 0.54
Instrument 2 0.01 0.01 0.01
Lab 6 0.67 0.01 0.11
Shift foreman 3 0.24 0.01 0.08
EPI helper 4 0.18 0.01 0.05
Control "A" finishing 2 0.01 0.01 0.01
Maintenance 13 4.69 0.01 1.50
From reference 2
93
Pet'ko et al [11] reported the results of environmental monitoring 
done in epichlorohydrin and dichlorhydrin-glycerine production units in 
Russia. The sampling technique employed was not specified. Concentrations 
of epichlorohydrin ranged from 19 to 21 mg/cu m (4.9-5.5 ppm) in the zone 
of employees who withdrew samples for quality control from the 
epichlorohydrin-production process. Airborne concentration of 
epichlorohydrin reached 12-15 mg/cu m (3.1-3.9 ppm) during the filling of 
tanks with epichlorohydrin. During an emergency caused by mechanical 
difficulties, a concentration range of 210-211 mg/cu m (54.6-54.9 ppm) was 
recorded.
Fomin [28] reported that, at about 100-200 meters from a factory 
discharging epichlorohydrin into the atmosphere, the airborne 
epichlorohydrin concentration exceeded the maximum permissible 
concentration of 0.2 mg/cu m by factors of 2.5-6. At a distance of 400 
meters, 5 of 29 samples indicated that epichlorohydrin concentrations 
exceeded the 0.2 mg/cu m limit. No epichlorohydrin was detected at 
distances of 500-600 meters from the factory.
Sampling and Analysis
There are many general methods of sampling and analysis for organic 
vapors. A few of these have been adapted or found suitable for 
epichlorohydrin.
Impingers or bubblers containing distilled water have been used for 
epichlorohydrin vapor collection. [38,79] A 2-liter air sample is drawn
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through two bubblers in series, containing 8 ml of water each, at a 
sampling rate of 0.5 liter/minute. [79] When a test atmosphere was used, 
the percentage of epichlorohydrin trapped in the first bubbler decreased as 
the atmospheric concentration decreased. At a concentration of 20 mg/cu m 
(approximately 5.2 ppm), the efficiency of one bubbler was 80%. For
greater accuracy, two bubblers were recommended. The main disadvantage of 
such a sampling system is the difficulty in obtaining a personal sample. 
Since the collection medium is liquid, some sample loss can occur from 
spillage and evaporation. Epichlorohydrin vapor has also been collected in 
bubblers containing sulfuric acid. [80]
Plastic bags [81-84] and glass bottles [85] have been used for
sampling industrial air. Usually, this has involved obtaining a volume of
air over a very short time, from a few seconds to 2 minutes. Such sampling 
techniques are best suited for obtaining information on ceiling 
concentrations. However, sampling with plastic bags has been modified to 
determine TWA concentrations. [84] Aluminum foil-polyester laminate bags 
or Teflon bags were used. The advantage of this technique is that both TWA 
and excursion values can be estimated. However, 24-hour sample losses were 
20-26% and 19-40% for epichlorohydrin stored in Teflon and aluminum foil- 
polyester laminate bags, respectively. These losses occurred when the 
epichlorohydrin concentration in the air sampled ranged from 5 to 27 ppm. 
[84] Bulkiness of the containers has created transportation problems.
Adsorption on silica gel [80,86,87] or activated charcoal [88-90] is 
commonly used to collect organic vapors. Reid and Halpin [91] found 
charcoal tubes both efficient and practical for sampling a number of 
chlorinated hydrocarbons. At present, a major manufacturing company uses
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charcoal tubes for sampling epichlorohydrin. [2] Epichlorohydrin in air 
has been sampled at 20-30 liters/hour through a glass tube (45-mm long and 
3 mm in diameter) containing 0.1 g silica gel. [80] Data on collection 
efficiency were not given. However, sampling with silica gel in high 
humidity may result in considerable sample loss from the displacement of 
the organic vapors by water vapor. Whitman and Johnston [92] reported that 
this problem could be overcome with a molecular sieve prefilter. They used 
a 5-Angstrom molecular sieve to remove water vapor from gas streams without 
interfering with the passage of aromatic hydrocarbons. White et al [89] 
have described the design of activated charcoal tubes suitable for 
sampling, and such tubes are commercially available. Adsorption on 
activated charcoal is the preferred sampling method for epichlorohydrin 
alone for several reasons: epichlorohydrin is not displaced by water vapor
as it is from silica gel; it is a simpler, more convenient procedure than 
the use of plastic bags or of a bubbler; it uses a small, portable sampling 
device, and the difficulties associated with handling liquids are 
eliminated. Disadvantages are that the amount of sample that can be 
collected is limited by the number of milligrams that the charcoal tube 
will hold before overloading, and that the more volatile compounds can 
migrate to the backup section during storage before analysis.
Various methods used for analyzing the collected samples have 
included colorimetry, [79,80] infrared analysis, [93,94] and gas 
chromatography. [90,95] Colorimetric analysis suitable for analyzing 
epichlorohydrin in an aqueous solution has been used. [79] The 
colorimetric method [79] is based on the oxidation of epichlorohydrin in 
aqueous solution by periodic acid. Epichlorohydrin in water is hydrolyzed
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to a glycol which is then oxidized to formaldehyde. Epichlorohydrin 
solutions of known concentrations are prepared to obtain the standard
curve. The formaldehyde further reacts with sodium arsenite and
acetylacetone reagent to form a yellow complex. The acetylacetone reagent 
solution is prepared by mixing ammonium acetate, acetylacetone, and glacial 
acetic acid in water. Maximum optical density of the yellow complex occurs
at about 412 nm. This method was capable of determining as little as 20jug
of epichlorohydrin. Data on the efficiency of the analytical technique 
were not given. [79] Formaldehyde, or any substance that may yield 
formaldehyde under the test conditions, will interfere. Compounds that 
contain or would form vicinal terminal hydroxy groups, such as ethylene 
glycol and ethylene oxide, will also interfere.
A colorimetric method [80] suitable for analyzing epichlorohydrin 
collected in sulfuric acid also has been used. Air containing 
epichlorohydrin was drawn through two bubblers containing 3 ml of 20% 
sulfuric acid and 4 ml of 10% sulfuric acid, respectively. The content of 
the first bubbler was diluted 1:1 with water. A 3-ml sample was then 
oxidized with 0.5 ml of 3% potassium iodate solution and allowed to stand 
for 30 minutes, during which time a yellow color developed. A 10% sodium 
sulfite solution was added and the mixture was shaken until the color 
disappeared. One milliliter of Schiff's reagent was then added and the 
intensity of the resulting color (magenta) was measured 1 hour later. The 
initial reactions occurring were similar to those in the previously 
discussed colorimetric method. [79] Epichlorohydrin is hydrolyzed by 
sulfuric acid and the resulting glycol is oxidized to formaldehyde by the 
iodate. The formaldehyde then reacts with Schiff's reagent to form a
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magenta complex. Sodium sulfite is added to reduce the unreacted iodate. 
It was found that this method was capable of analyzing 0.01-0.1 mg 
epichlorohydrin in a 6-ml solution. Data on sensitivity, specificity, and 
interferences were not reported. However, the same compounds that would 
interfere with the previously discussed colorimetric technique, [79] such 
as ethylene oxide and ethylene glycol, would also interfere with this 
method. In addition, many aldehydes would interfere.
The formaldehyde can also react with phenylhydrazlne hydrochloride to 
form phenylhydrazone. [38] The phenylhydrazone of formaldehyde reacts with 
potassium ferricyanide to form a colored complex. The maximum optical 
density of this complex occurs at about 500 nm. Epichlorohydrin 
concentrations ranging from 0.45 to 14 mg/cu m in air were determined by 
this method. Precision tests indicated the maximum error between the two 
determinations to be only 0.3%.
The infrared absorption spectrum of epichlorohydrin showed the 
typical terminal epoxide absorption bands. [93] The minimum amount of 
epichlorohydrin that was detected by infrared absorption was 0.3% (v/v in 
aqueous solution). [94] However, a practical and detailed technique using 
infrared analysis for a quantitative determination of epichlorohydrin has 
not been developed.
In recent years, gas chromatography has become the method of choice 
of most investigators for separation and the analysis of organic materials. 
[89,90] It offers excellent specificity and sensitivity and is suitable 
for analyzing samples of airborne contaminants collected on charcoal. 
Interferences are few, and most of those which do occur can be eliminated 
by altering the instrumental conditions. Muganlinsky et al [95] developed
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a linear temperature program to analyze epichlorohydrin in the presence of 
chlorinated hydrocarbons which may be present as impurities.
The recommended methods for sampling and analyzing epichlorohydrin 
are collection by charcoal tube and analysis by gas chromatography. 
Sampling involves the collection of personal samples on charcoal tubes, and 
analysis involves desorption with carbon disulfide and measurement with a 
gas chromatograph equipped with a suitable detector. [90] Details of the 
recommended methods are given in Appendices I and II. The recommended 
methods are not validated for monitoring or for an environment that may 
contain other substances that may interfere. Other sampling and analytical 
methods equivalent in accuracy, precision, and sensitivity may be used.
Engineering Controls
Engineering design for safety in working with epichlorohydrin should 
be such as to reduce the concentration of airborne epichlorohydrin. Closed 
systems, properly operated and maintained, should be used in all cases 
where practicable. Frequent tests must be conducted for leaks in closed 
systems. Where closed systems are not feasible, well-designed local
exhaust ventilation systems must be provided. Guidance for design can be 
found in Industrial Ventilation— A Manual of Recommended Practice, [96] or 
more recent revisions, and in Fundamentals Governing the Design and 
Operation of Local Exhaust Systems, ANSI Z9.2-1971. [97] In operations 
where epichlorohydrin is transferred, changed, or discharged into otherwise 
normally closed systems, continuous local exhaust should be provided at the 
transfer point. Sufficient ventilation with clean air should be maintained
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in the area to permit the correct operation of the local exhaust system.
Respiratory protective equipment is not an acceptable substitute for 
proper engineering controls but should be available in emergencies and for 
nonroutine maintenance and repair work situations.
100
V. DEVELOPMENT OF STANDARD
Basis for Previous Standards
In 1965, the American Conference of Governmental Industrial 
Hygienists (ACGIH) adopted a threshold limit value (TLV) of 5 ppm 
(approximately 19 mg/cu m) for epichlorohydrin. [98]
In a personal communication cited in the Documentation of Threshold 
Limit Values for Substances in Workroom Air, [99] Smyth and Pozzani stated 
that cases of skin burns and sensitization, with resulting intolerance to 
trivial exposures, occurred in workers during the handling and production 
of epichlorohydrin. Systemic poisoning caused by epichlorohydrin 
penetration of the skin also was reported. Therefore, the ACGIH 
epichlorohydrin TLV listing was accompanied by a "skin" notation. [99] 
Such a notation refers to the potential contribution to overall exposure by 
the cutaneous route, including mucous membranes and eyes, either by 
airborne or, more particularly, by direct skin contact with liquid 
epichlorohydrin. This designation is intended to indicate the need for 
appropriate measures for the prevention of cutaneous absorption so that the 
TLV is not invalidated.
The present federal standard (29 CFR 1910.1000) for occupational 
exposure to epichlorohydrin is 5 ppm as an 8-hour TWA limit. This standard 
was based on the ACGIH TLV.
In Russia and in France, the maximum allowable concentration (MAC) in 
the industrial environment is 1 mg/cu m (0.26 ppm). [100] In the Rumanian 
Socialist Republic, 10 mg/cu m (approximately 2.6 ppm) of epichlorohydrin 
is the maximum concentration allowed in the occupational environment. [38]
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In the Federal Republic of Germany, the permissible environmental exposure 
limit is 18 mg/cu m (approximately 3.6 ppm), and 5 mg/cu m (approximately 1 
ppm) in the German Democratic Republic. [100] The bases for these 
standards are not given. Air and water quality standards have not been 
found, although one recommendation of such a value (0.2 mg/cu m) has been 
presented. [28]
Basis for the Recommended Standard
The induction of severe necrotic lesions occurring after dermal 
contact with epichlorohydrin has been reported. [35] A latency period 
lasting from several minutes to several hours between contact with liquid 
epichlorohydrin and the appearance of skin damage was observed. 
Epichlorohydrin penetrates the skin and can induce adverse systemic effects 
following dermal contact. [25,27,35] These necrotic lesions have been 
compared with those induced by X-rays or by other alkylating agents such as 
ethylene oxide or propanesultone. [35] These observations require,
therefore, that complete skin protection be provided to employees handling 
epichlorohydrin. Care must be taken to ensure that shoes, gloves, and 
other protective clothing are made of material impervious to 
epichlorohydrin.
Reports on humans occupationally exposed to epichlorohydrin have 
identified the effects resulting from acute exposure. [28,37,38] Transient 
burning of the eyes and nasal passages in persons after exposure to 
epichlorohydrin at a concentration of 20 ppm was reported, [37,38] while 
exposure at 40 ppm caused eye and nasal irritation lasting 48 hours. 
[37,38] Lung edema and kidney lesions were reported in humans exposed to
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epichlorohydrin at concentrations greater than 100 ppm for very short 
periods. [37,38] Changes in the voltage of the peaks of the alpha rhythm 
of the EEG measurements of volunteers exposed to epichlorohydrin at 0.08 
ppm for a few minutes were reported by Fomin. [28] Since the significance 
of the changes observed in this component of the EEG measurements is not 
known, further research needs to be conducted in this area before any 
interpretations can be made. Acute exposure to epichlorohydrin at a high, 
but unknown, concentration [33] caused irritation of the eyes and throat, 
nausea, and dyspnea; bronchitis with bronchiolar constrictions and enlarged 
liver were suspected to have resulted from this single overexposure. These 
findings [28,37,38] suggest that a ceiling is required. Since acute 
effects have been observed on humans at 20 ppm, and the lowest 
concentration which induces effects during a short interval has not been 
identified, a ceiling concentration of 19 mg/cu m (5 ppm), based on 
professional judgment, is recommended to protect even the more sensitive 
fraction of the working population from these adverse effects.
The existing federal standard of 5 ppm is based on the 1968 TLV. 
Further information on cumulative aspects of toxicity such as sterility, 
carcinogenesis, and mutagenesis have been reported in subsequent studies. 
[28,31,32,39,64-66,74]
The report by Shumskaya et al [32] indicated that disrupted liver 
function and kidney damage developed in rats after single 4-hour exposures 
to epichlorohydrin at concentrations of 91, 5.2, or 1.8 ppm, the effects 
being least severe at 1.8 ppm. The authors did not indicate whether the 
chamber was static or dynamic. Thus, data from this study suggest that 
minor adverse effects are observed on animals inhaling a total amount of
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1.0 mg/kg within 4 hours. The data demonstrate the induction of measurable
biochemical perturbations, but cannot be used to predict the cumulative
effects to be expected from long-term exposures to epichlorohydrin.
Kremneva and Tolgskaya [27] have reported neither mortality nor signs 
of intoxication in rats exposed for 3 hours at about 5.2-15.6 ppm daily for 
up to 6.5 months. Lags in body weight gains, initial increases in the 
excitability thresholds, elevations in blood pressures, and fluctuations in 
oxygen consumptions were observed in the animals when compared with the 
controls. They concluded that 5.2-15.6 ppm of epichlorohydrin approximated 
the threshold in rats, which is interpreted to mean that no measurable 
adverse effects occurred below these concentrations.
The minimal concentration which has been observed to induce effects 
on rats (about 5 ppm) is used to approximate the permissible exposure in 
the occupational environment by weighing additional risk factors. The 
chronic effects for which risk must be considered are carcinogenesis, 
mutagenesis, and antifertility, as well as liver, kidney, and lung damage.
Van Duuren et al [64] found that a single application of 2.0 mg of 
epichlorohydrin on mouse skin initiated the tumorigenic process in at least 
9 of the 30 experimental mice when it was followed by triweekly 
applications of a promoter (phorbol myristate acetate) for the remainder of
the 385-day experiment. The promoter alone induced papillomas in 3 of 30
mice. No initiation was observed in the control animals. Weil et al [63] 
and Van Duuren et al [64] found that repeated applications of 
epichlorohydrin on mouse skin did not induce a significant number of skin 
lesions. Van Duuren et al [64] found that sarcoma and adenocarcinoma were 
induced in 6 of 50 mice given weekly subcutaneous injections of 1.0 mg of
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epichlorohydrin in 0.05 ml of tricaprylln (P values less than 0,05). Only 
1 of the 50 control animals injected with tricaprylin alone developed 
sarcoma. No sarcomas developed in untreated control animals. The tesults 
were considered significant only when the P value was less than or equal to 
0.05.
Antifertility effects, including persistent sterility, have been 
induced in animals exposed to epichlorohydrin. [39-41] Twelve repeated 
oral doses of 15 mg/kg of epichlorohydrin sterilized male rats. [41] Even 
though sterility occurred in animals following oral administration of 
epichlorohydritt, it is probable that similar effects would be produced by 
inhalation, since severe systemic effects have been observed after both 
dermal and inhalation exposures. [25,27] Epstein et al [61] did not 
observe any increase in the frequency of dead implantations in the uteri of 
mice following ip injections of 150 mg/kg of epichlorohydrin into the male 
rats mated to the females, nor did they provide any evidence of reduced 
fertility at this dosage.
Mutagenic effects of epichlorohydrin have been observed in microbial 
organisms and in the eukaryotic fruit fly, Drosophila melanogaster, 
following exposure to epichlorohydrin. [70] The number of point mutations 
observed in several microbial species increased as a function of 
epichlorohydrin concentration and duration of exposure. At present, an 
experimental relationship between the frequency of dead implantations and 
that of point mutations has not been observed. The positive results from 
the point mutation test systems in lower organisms, such as bacteria, [73- 
76] fungi, [71] and Drosophila melanogaster, [70] indicate that an 
increased risk of occurrence of point mutations may exist in human
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populations exposed to epichlorohydrin. The fact that preparations derived 
from the urine of workers exposed to 25 ppm of epichlorohydrin influenced 
the genetic mechanisms in Salmonella typhimurium (DJ Kilian, written 
communication, April 1976) is consistent with the existence of a genetic 
risk to human populations exposed to epichlorohydrin.
The total risk to the health of employees occupationally exposed to 
epichlorohydrin is the result of the independent risks due to 
carcinogenesis, mutagenesis, sterility, and damage to kidneys, liver, 
respiratory tract, and to the skin. At present, evidence for the existence 
of the risks, other than to skin depends primarily on data from 
experimental animal models. Concern for employee health requires that the 
probability of the occurrence of chronic effects be minimized. NIOSH 
recommends, therefore, that worker exposure to epichlorohydrin be limited 
to a concentration of 2 mg/cu m (0.5 ppm) as a TWA concentration. This 
value has been chosen on the basis of professional judgment, rather than on 
quantitative data which clearly distinguish no-effect concentrations from 
those at which adverse effects have been shown to occur in human 
populations. A TWA concentration of 2 mg/cu m of epichlorohydrin should 
protect the employee against injury to organs during the individual’s 
working lifetime, according to existing information. However, additional 
research is needed to provide support for the recommended environmental 
limit or to indicate the need for a different limit. The environmental 
limit implicitly assumes that the absorbed epichlorohydrin molecules will 
be detoxified by biochemical mechanisms, thereby reducing the risk of 
induction of human disease resulting from the cumulative toxicity of 
epichlorohydrin.
106
It is recognized that many employees handle small amounts of 
epichlorohydrin or work in situations where, regardless of the amount used, 
there is only negligible contact with epichlorohydrin. Under these 
conditions, it should not be necessary to comply with all of the provisions 
of the recommended standard, which has been prepared primarily to protect 
employee health under all circumstances. For these reasons, "occupational 
exposure to epichlorohydrin" is defined as exposure above one-half the TWA 
environmental limit, thereby delineating those work situations which do not 
require the expenditure of resources for environmental monitoring and 
associated recordkeeping. Because of nonrespiratory hazards such as the 
production of burns on the skin in the use of epichlorohydrin, NIOSH 
recommends that appropriate work practices and protective measures to limit 
such contact be required regardless of the concentration of airborne 
epichlorohydrin. Further, the observation of changes in the concentration 
of biochemical constituents [48] following human and animal exposure to 
epichlorohydrin suggest that the health of the exposed workers be monitored 
frequently. Thus, it is recommended that comprehensive medical 
examinations be offered to all employees subject to occupational exposure 
to epichlorohydrin and that the responsible physician consider the 
advisability of also administering any liver and kidney function tests.
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VI. WORK PRACTICES
Work practices must be designed to minimize or to prevent inhalation 
of epichlorohydrin and skin and eyes from coming into contact with 
epichlorohydrin. Good work practices are a primary means of controlling 
certain exposures and will often supplement other control measures.
Enclosure of materials, processes, and operations is completely 
effective as a control only when the integrity of the system is maintained. 
Such systems should be inspected frequently for leaks and any leaks found 
should be promptly repaired. Special attention should be given to the 
condition of seals and joints, access ports, and other such places. [101] 
Similarly, points of wear should be inspected regularly for damage.
Ventilation systems require regular inspection and maintenance to 
ensure their effective operation. The effects of any changes or additions 
to the ventilating system or to the operations being ventilated should be 
assessed promptly, including measurements of airflow and of environmental 
levels of epichlorohydrin under the new conditions. Work practices should 
not introduce obstructions or interferences which would reduce the 
effectiveness of the ventilating system.
A major hazard of handling epichlorohydrin that can be minimized by 
good work practice is that from skin contact. Observation of animals 
indicates that severe systemic poisoning and death may result from skin 
contact with epichlorohydrin. [25,27] Ippen and Mathies [35] reported 
several cases of severe chemical burns caused by dermal contact with 
epichlorohydrin. Brief skin contact causes chemical burns, while extended 
skin contact may cause extensive skin burns and severe systemic effects.
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The authors [35] also reported the occurrence of severe burns in an 
individual who spilled epichlorohydrin on his shoes which were not 
immediately removed. The severe effects are intensified by the penetration 
of epichlorohydrin into the clothing and shoes which act as reservoirs and 
continue the contact. For this reason, clothing contaminated with 
epichlorohydrin must be removed immediately and thoroughly laundered before 
reuse. Shoes on which epichlorohydrin is spilled are to be rendered 
unusable and discarded. The protective clothing must be made of material 
not permeable to epichlorohydrin. Penetration through three types of 
rubber has been measured [3] and found to be 9-11 minutes for nitrile 
rubber, 20-22 minutes for neoprene rubber, and 38-43 minutes for natural 
rubber. Since the penetration time is dependent on both the type of the 
rubber and the thickness, it is noteworthy that in this test [3] the 
thickness for each type of rubber was: 0.015 inches for nitrile rubber,
0.02 inches for neoprene rubber, and 0.030 inches for natural rubber. 
Since uniform thickness was not used, the data provide only a rough 
estimate of relative rate of epichlorohydrin penetration through different 
types of rubber. Nevertheless, it is evident that epichlorohydrin does 
penetrate rubber. When it is necessary to work with liquid 
epichlorohydrin, special handling techniques should be employed routinely. 
All body surfaces should be protected against contact with the liquid by 
the use of gloves, aprons, face shields, goggles, and other protective 
equipment or clothing. Ippen and Mathies [35] have pointed out that 
enclosed processes minimize any exposures; therefore, engineering controls 
are the most suitable control measures. Closed systems operating under 
negative pressure are particularly effective.
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The flash point of epichlorohydrin is 93 F (70 C). [2] It is 
classified, therefore, as a flammable liquid of Class IC in 29 CFR 
1910.106(a)(19)(iii). The lower and upper explosive limits in air at 20 C 
are 3.8 and 21.0%, respectively. [2] Hence, fire is a potential hazard 
because of the presence of epichlorohydrin. Recommended work practices 
should ensure that no flames or other sources of ignition, such as smoking, 
be permitted in the area where epichlorohydrin is stored or handled.
Safety showers, eyewash fountains, and fire extinguishers shall be 
located in or near areas where epichlorohydrin splashes are likely to occur 
and shall be properly maintained. Handwashing facilities, soap, and water 
must be available to the employees. As good hygiene practices, eating in 
epichlorohydrin work areas shall be prohibited and handwashing before 
eating recommended.
In summary, precautions must be exercised against overexposure to 
epichlorohydrin. It is important that employees be informed before job 
placement of hazards associated with the use of epichlorohydrin and when 
any process changes are made that may alter their epichlorohydrin exposure. 
Appropriate emergency procedures should be stressed. Recommended labels 
and posters must be displayed. The US Department of Labor "Material Safety 
Data Sheet," or a similar OSHA-approved form, must be filled out. In 
addition, all employees in the epichlorohydrin area should know where the 
safety sheet is posted. If all these work practices are observed and good 
engineering controls are installed, employees working with epichlorohydrin 
should be adequately protected from hazards associated with 
epichlorohydrin.
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VII. RESEARCH NEEDS
Epidemiologic Study
One epidemiologic study involving workers exposed to epichlorohydrin
has been found (DJ Kilian, written communication, April 1976). However,
deficiencies such as the lack of a control group, the absence of 
measurements of exposure concentrations, and failure to indicate people 
lost to observation have limited the usefulness of the study. A 
retrospective controlled cohort study of a working population exposed 
chiefly to epichlorohydrin for a longer duration should provide valuable 
information.
Mutagenic Effect
This effect must be systematically investigated in greater depth with 
respect to dose, time, and route in both lower organisms and mammals. 
Animal tests using various doses, schedules, and routes of administration 
should be performed to see whether epichlorohydrin is a mutagen in mammals. 
Specific locus tests or heritable translocations should be considered. 
Animals should also be tested to see whether epichlorohydrin has any 
cytogenic effects.
Kidney Function in Workers Exposed to Epichlorohydrin
The impairment of kidney function as a result of epichlorohydrin
exposure has been found in animals. As yet, there is no evidence that such 
injury also occurs in workers exposed to epichlorohydrin. Since a segment
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of a working population which is exposed primarily to epichlorohydrin can 
be identified, kidney function tests should be given periodically to 
determine whether any changes in kidney function are occurring as a result 
of occupational exposure to epichlorohydrin.
Skin Sensitization
Although epichlorohydrin is commonly stated to be a sensitizer of the 
skin, the data that have been found in this regard are far from complete or 
persuasive. [11,36] Additional information on the degree and character of 
sensitization of the skin of humans is highly desirable. Some measure of 
variability in the skin response would be most useful.
Electroencephalographic (EEG) Studies
The index of effect by epichlorohydrin on humans that seems to be the 
most sensitive on the basis of the available information is a change in the 
voltage of the alpha rhythm of the EEG. [28] More information on the dose- 
response relationship for this effect and on its correlation with more 
usual alterations of function would be of great value.
Chronic Animal Exposure Studies
Inhalation exposure of various species of animals at several 
concentrations of epichlorohydrin up to the maximum tolerated 
concentration, 8 hours/day, 5 days/week, for at least 2 years, is 
recommended. These experiments should include measurement of food intake, 
monitoring of several biochemical parameters, gross and histopathologic
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examinations of important organs and tissues including at least the liver, 
kidneys, respiratory tract, and CNS.
Metabolism and Distribution
The pathways of distribution and of elimination of epichlorohydrin as 
a function of dose route and dose rate in mammals have not been 
investigated. It is critical to determine which fraction of the dose
reacts with the functionally essential biomolecules and which fraction is 
inactivated by detoxifying reactions. Both in vivo and in vitro studies 
should be conducted to determine the pathways. It is critical to determine
the concentration at which reaction with functional biomolecules is a
linear function of dose in intact animals.
Chemical Reactivity Toward all Classes of Biologic Nucleophiles
To acquire a better understanding of the reaction of epichlorohydrin 
with cells and organelles, experiments to determine its reaction with 
various classes of nucleophiles found in biologic systems should be carried 
out.
Hypertension
Kidney damage is often accompanied by hypertension. Since 
epichlorohydrin causes kidney damage in animals, studies should be 
conducted to see whether hypertension is also induced by epichlorohydrin 
exposure.
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IX. APPENDIX I
The following sampling method is adapted from those described by 
White et al [89] and in Method No. S118 of the Physical and Chemical 
Analysis Branch of NIOSH. [90]
Atmospheric Sampling
Collect breathing zone or personal samples representative of the 
individual employee's exposure. At the time of sample collection, record a 
description of sampling location and conditions, equipment used, time and 
rate of sampling, and any other pertinent information. Collect enough 
samples to permit calculation of a TWA exposure for every operation or 
location in which there is exposure to epichlorohydrin.
(a) Equipment
The sampling train consists of a charcoal tube and a vacuum pump.
(1) Charcoal tubes: Glass tubes, with both ends flame-
sealed, 7-cm long with a 6-mm OD and a 4-mm ID, containing two sections of 
20/40 mesh activated charcoal separated by a 2-mm portion of polyurethane 
foam. The primary section contains 100 mg of charcoal, the backup section, 
50 mg. A 3-mm portion of polyurethane foam is placed between the outlet 
end of the tube and the backup section. A plug of glass wool is placed in 
front of the primary section. Tubes with the above specifications are 
commercially available.
(2) Pump: A battery-operated pump, complete with clip for
METHOD FOR SAMPLING EPICHLOROHYDRIN IN AIR
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attachment to the employee's belt, capable of operating at 200 ml/minute or 
less.
(b) Calibration
The accurate calibration of a sampling pump is essential to the 
correct interpretation of the volume sampled. The frequency of calibration 
is dependent on the use, care, and handling to which the pump is subjected. 
Pumps should also be recalibrated if they have been misused or if they have 
just been repaired or received from a manufacturer. If the pump receives 
hard usage, more frequent calibration may be necessary. Maintenance and 
calibration should be performed on a regular schedule and records of these 
should be kept.
Ordinarily, pumps should be calibrated in the laboratory both before 
they are used in the field and after they have been used to collect a large 
number of field samples. The accuracy of calibration is dependent on the 
type of instrument used as a reference. The choice of calibration 
instrument will depend largely upon where the calibration is to be 
performed. For laboratory testing, a soapbubble meter is recommended, 
although other standard calibrating instruments can be used. The actual 
setups will be similar for all instruments.
Instructions for calibration with the soapbubble meter follow. If 
another calibration device is selected, equivalent procedures should be 
used. The calibration setup for personal sampling pumps with a charcoal 
tube is shown in Figure XIII-2. Since the flowrate given by a pump is 
dependent on the pressure drop across the sampling device, in this case a 
charcoal tube, the pump must be calibrated while operating with a 
representative charcoal tube in line.
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(1) Check the voltage of the pump battery with a voltmeter 
to assure adequate voltage for calibration. Charge the battery if 
necessary.
(2) Break the tips of a charcoal tube to produce openings 
of at least 2 mm in diameter.
(3) Assemble the sampling train as shown in Figure XIII-2.
(4) Turn on the pump and moisten the inside of the 
soapbubble meter by immersing the buret in the soap solution. Draw bubbles 
up the inside until they are able to travel the entire buret length without 
bursting.
(5) Adjust the pump flowmeter to provide the desired
flowrate.
(6) Check the water manometer to ensure that the pressure 
drop across the sampling train does not exceed 2.5 inches of water at 200 
ml/minute.
(7) Start a soapbubble up the buret and measure with a 
stopwatch the time it takes the bubble to move from one calibration mark to 
another.
(8) Repeat the procedure in (7) above at least three times, 
average the results and calculate the flowrate by dividing the volume 
between the preselected marks by the time required for the soapbubble to 
traverse the distance. If, for the pump being calibrated, the volume of 
air sampled is calculated as the product of the number of strokes times a 
stroke factor (given in units of volume/stroke), the stroke factor is the 
quotient of the volume between the two preselected marks divided by the 
number of strokes.
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(9) Data for the calibration include the volume measured,
elapsed time or number of strokes of the pump, pressure drop, air 
temperature, atmospheric pressure, serial number of the pump, date, and
name of the person performing the calibration.
(c) Sampling Procedure
(1) Break both ends of the charcoal tube to provide
openings of at least 2 mm, which is half the ID of the tube. A smaller
opening causes a limiting orifice effect which reduces the flow through the
tube. The smaller section of charcoal in the tube is used as a backup
section and therefore is placed nearest the sampling pump. Use tubing to
connect the back of the tube to the pump, but tubing must never be put in 
front of the charcoal tube. The tube is supported in a vertical position 
in the employee's breathing zone.
(2) Sample a maximum of 20 liters of air at a flowrate of
200 ml/minute. For the determination of ceiling concentrations the
sampling time is 15 minutes.
(3) Measure and record the temperature and pressure of the 
atmosphere being sampled.
(4) Treat at least one charcoal tube in the same manner as
the sample tubes (break, seal, and ship), except draw no air through it. 
This tube serves as a blank.
(5) Immediately after samples are collected, cap the
charcoal tubes with plastic caps. Do not use rubber caps. To minimize
breakage during transport, pack capped tubes tightly in a shipping 
container.
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X. APPENDIX II
The following analytical method is adapted from those described by
White et al, [89] by R Hill (written communication, June 1976), and in 
Method No. S118 of the Physical and Chemical Analysis Branch of NIOSH. [90]
Principle of the Method
Epichlorohydrin vapor trapped on charcoal from a known volume of air 
is desorbed with carbon disulfide. An aliquot of the desorbed sample is 
injected into a gas chromatograph. The area of the resulting peak is
determined and compared with those obtained from injection of standards.
Range and Sensitivity
This method was developed to analyze epichlorohydrin over the range 
of 11.7-43.1 mg/cu m at an atmospheric temperature and pressure of 23 C and 
765 mmHg. [90] For a 20-liter sample, the useful range of this method was
2-60 mg/cu m at a detector sensitivity that gives nearly full deflection on
the strip chart recorder for a 1-mg sample. The method is capable of 
measuring smaller amounts down to 50 ppb, as demonstrated by Hill (written 
communication, June 1976) . Desorption efficiency must be determined over
the range used.
The upper limit of the range of the method is dependent on the 
absorptive capacity of the charcoal tube. This capacity varies with the
ANALYTICAL METHOD FOR EPICHLOROHYDRIN
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concentrations of epichlorohydrin and other substances in the air. The 
first section of the charcoal tube held at least 2 mg of epichlorohydrin 
when a test atmosphere containing 43.1 mg/cu m of epichlorohydrin in air 
was sampled at 0.185 liter/minute for 240 minutes; at that time, the 
concentration of epichlorohydrin in the effluent was less than 5% of that 
in the influent.
Interferences
Any compound which has about the same retention time as 
epichlorohydrin under the gas-chromatographic conditions described in this 
method will interfere with the analysis. This type of interference can be 
overcome by changing the operating conditions of the instrument, usually 
the column, the column temperature, or both. Epichlorohydrin appears to be 
stable under 80% humidity conditions.
Precision and Accuracy
In a collaborative test, the total relative error at 5 ppm 
epichlorohydrin (18.9 mg/cu m) was 0.7%. However, definition of total 
relative error was not given. Hill (written communication, June 1974) has 
determined that it is possible to analyze down to 0.25 /¿g/liter. Samples 
were collected from an 80% relative humidity atmosphere containing 
epichlorohydrin. Following a storage period of 14 days, the charcoal tubes 
were analyzed. The results of the analyses of two sets were 8.07 ± 0.25 
and 11.64 ± 0.32 pg/tube. Hill found that the percent relative standard 
deviation of each set, which reflects the precision of the total sampling
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and analytical procedure, was 7.21 and 5.33%, respectively. Under these 
conditions, the desorption efficiency was estimated to be 82.7%.
Apparatus
(a) Gas chromatograph equipped with a flame ionization detector.
(b) Stainless steel column (12 feet x 1/8 inch) with 10% carbowax 
20 M stationary phase on 80/100 mesh acid-washed DMCS Chromosorb W solid 
support. Another column that can be used is stainless steel (6 feet x 2-mm 
ID) with 80/100 mesh Chromosorb 101. Other columns which achieve the 
desired separation may be used.
(c) A mechanical or electronic integrator or a recorder for
determining peak area.
(d) Small glass-stoppered test tubes or equivalent.
(e) A 10-/il syringe and other conveniently sized syringes for
preparation of the standards.
(f) Delivery pipets, 1.0-ml pipets.
Reagents
(a) Carbon disulfide, chromatographic quality.
(b) Epichlorohydrin, reagent grade.
(c) Helium, Bureau of Mines Grade.
(d) Hydrogen, purified.
(e) Compressed air, filtered.
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All glassware used for the laboratory analysis should be washed in 
detergent and rinsed with tap and distilled water.
(a) Preparation: Score each charcoal tube, including the blank 
from field samples, with a file and break open in front of the first 
section of charcoal. Remove and discard the glass wool. Transfer the 
charcoal in the first (larger) section to a small stoppered test tube. 
Remove and discard the foam separating sections and transfer the second 
section of charcoal to another test tube. Analyze the two charcoal 
sections separately.
(b) Desorption: Prior to analysis, pipet 1.0 ml of carbon
disulfide into each test tube to desorb the epichlorohydrin from the 
charcoal. Desorption is complete in 30 minutes if the sample is stirred 
occasionally.
EXTREME CAUTION MUST BE EXERCISED AT ALL TIMES WHEN USING CARBON 
DISULFIDE BECAUSE OF ITS HIGH TOXICITY AND FIRE AND EXPLOSION 
HAZARDS. IT CAN BE IGNITED BY HOT STEAM PIPES. ALL WORK WITH 
CARBON DISULFIDE MUST BE PERFORMED UNDER AN EXHAUST HOOD.
(c) Typical gas chromatographic operating conditions for 
Chromosorb 101 column:
(1) 20 ml/minute helium flowrate.
(3) 200 C injector temperature.
(3) 230 C manifold temperature (detector).
(4) 135 C isothermal oven or column temperature.
Analysis of Samples
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(d) Injection: The first step in the analysis is the injection of 
the sample into the gas chromatograph. Employ the solvent flush injection 
technique. This eliminates difficulties arising from blowback or 
distillation within the syringe needle, thus increasing the accuracy and 
reproducibility of the injected sample volume. First, flush the 10.0-jil 
syringe with solvent several times to wet the barrel and plunger, then draw
3.0 nl of solvent into the syringe. Next, remove the needle from the 
carbon disulfide and pull the plunger back about 0.2 jil to separate the 
solvent flush from the sample with an air pocket to be used as a marker. 
Immerse the needle in the sample and withdraw a 5.0-pl portion, taking into 
consideration the volume of the needle since the sample in the needle, will 
be completely injected. After the needle is removed from the sample and 
prior to injection in the gas chromatograph, pull the plunger back a short 
distance to minimize sample evaporation from the tip. Make duplicate 
injections of each sample and of the standard. No more than a 3% 
difference between the peak areas of the similar samples should be accepted 
as a valid result.
(e) Measurement of area: The areas of the sample peaks are 
measured by electronic integration or some other suitable method of area 
measurement. Preliminary sample results are read from a standard curve 
prepared as outlined below.
Determination of Desorption Efficiency
The desorption efficiency of a particular compound can vary from one 
laboratory to another and also from one batch of charcoal to another. 
Thus, it is necessary to determine at least once the percentage of
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epichlorohydrin that is removed in the desorption process. Repeat this 
procedure for each new batch of charcoal used.
Place the same amount of activated charcoal as in the first section 
of the sampling tube (100 mg) into a 5-cm, 4-mm ID glass tube; flame seal 
at one end. This charcoal must be from the same batch as that used in 
sampling and can be obtained from unused charcoal tubes. Cap the open end 
with Parafilm or equivalent. Inject a known amount of hexane solution 
containing 94.5 mg/ml of epichlorohydrin directly into the activated 
charcoal with a microliter syringe and cap the tube with more Parafilm or 
equivalent.
Prepare at least five tubes in this manner and allow to stand 
overnight or longer to ensure complete adsorption of the epichlorohydrin on 
the charcoal. These five tubes are referred to as the samples. Treat a 
parallel blank tube in the same manner, except add no epichlorohydrin to 
it. Desorb and analyze the sample and blank tubes in exactly the same 
manner as the sampling tube described for unknown air samples.
Prepare two or three standards by injecting the same volume of 
epichlorohydrin into 1.0 ml of carbon disulfide with the same syringe used 
in the preparation of the sample. These are analyzed with the samples.
The desorption efficiency equals the difference between the average 
peak area of the samples and that of the blank divided by the average peak 
area of the standards, or:
desorption efficiency = average weight recovered (mg)
weight added (mg)
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Calibration and Standards
It is convenient to express the concentration of standards in terms 
of mg/ml of carbon disulfide because samples are desorbed in 1 ml of carbon 
disulfide. Use the density of epichlorohydrin to convert milligrams into 
microliters for easy measurement with a microliter syringe. Prepare a 
series of standards varying in concentration over the range of interest and 
then analyze under the same gas-liquid chromatographic conditions and 
during the same time period as the unknown samples. Prepare standard 
curves by plotting concentration in mg/ml versus peak area.
Calculations
Read the weight in milligrams corresponding to the total peak area 
from the standard curve. No volume corrections are needed because the 
standard curve is based on mg/ml carbon disulfide and the volume of sample 
injected is identical to the volume of the standards injected.
Make corrections for the blank from the field sampling for each 
sample by subtracting the amounts of epichlorohydrin found on the front and 
back sections of the blank from the amounts found in the respective 
sections of the sample:
corrected amount = amount on sample - amount on blank
Add the corrected amounts present in the front and in the backup 
sections of the same sample tube to determine the total amount of 
epichlorohydrin in the sample. Divide this total amount by the desorption
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efficiency to obtain the adjusted total amount of epichlorohydrin in the 
sample:
adjusted total amount =  total amount
desorption efficiency
The concentration of epichlorohydrin in the air sampled, expressed in
mg/cu m, is given by the quotient of the adjusted amount in mg divided by
the volume of air sampled in cu m:
concentration (mg/cu m) = adjusted amount (mg)
volume (cu m)
Another method of expressing concentration is ppm:
concentration (ppm) = concentration (mg/cu m) x 24.45 x 760 x (T + 273)
MW P 298
where:
24.45 = molar volume (liter/mole) at 25 C and 760 mmHg
760 - standard pressure
P = pressure (mmHg) of air sampled
T = temperature (degrees C) of air sampled
MW = molecular weight of epichlorohydrin (g/mole)
298 = standard temperature (degrees K)
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XI. APPENDIX III
MATERIAL SAFETY DATA SHEET
The following items of information which are applicable to a specific 
product or material shall be provided in the appropriate block of the 
Material Safety Data Sheet (MSDS).
The product designation is inserted in the block in the upper left 
corner of the first page to facilitate filing and retrieval. Print in 
upper case letters as large as possible. It should be printed to read
upright with the sheet turned sideways. The product designation is that 
name or code designation which appears on the label, or by which the 
product is sold or known by employees. The relative numerical hazard 
ratings and key statements are those determined by the rules in Chapter V, 
Part B, of the NIOSH publication, An Identification System for 
Occupationally Hazardous Materials. The company identification may be 
printed in the upper right corner if desired.
(a) Section I. Product Identification
The manufacturer's name, address, and regular and emergency telephone 
numbers (including area code) are inserted in the appropriate blocks of
Section I. The company listed should be a source of detailed backup
information on the hazards of the material(s) covered by the MSDS. The 
listing of suppliers or wholesale distributors is discouraged. The trade 
name should be the product designation or common name associated with the 
material. The synonyms are those commonly used for the product, especially 
formal chemical nomenclature. Every known chemical designation or
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competitor's trade name need not be listed.
(b) Section II. Hazardous Ingredients
The "materials" listed in Section II shall be those substances which 
are part of the hazardous product covered by the MSDS and individually meet 
any of the criteria defining a hazardous material. Thus, one component of 
a multicomponent product might be listed because of its toxicity, another 
component because of its flammability, while a third component could be 
included both for its toxicity and its reactivity. Note that an MSDS for a 
single component product must have the name of the material repeated in 
this section to avoid giving the impression that there are no hazardous 
ingredients.
Chemical substances should be listed according to their complete name 
derived from a recognized system of nomenclature. Where possible, avoid 
using common names and general class names such as "aromatic amine," 
"safety solvent," or "aliphatic hydrocarbon" when the specific name is 
known.
The "%" may be the approximate percentage by weight or volume 
(indicate basis) which each hazardous ingredient of the mixture bears to 
the whole mixture. This may be indicated as a range or maximum amount, ie, 
"10-40% vol" or "10% max wt" to avoid disclosure of trade secrets.
Toxic hazard data shall be stated in terms of concentration, mode of 
exposure or test, and animal used, eg, "100 ppm LC50-rat," "25 mg/kg LD50- 
skin-rabbit," "75 ppm LC man," or "permissible exposure from 29 CFR 
1910.1000," or, if not available, from other sources of publications such 
as the American Conference of Governmental Industrial Hygienists or the 
American National Standards Institute Inc. Flashpoint, shock sensitivity,
135
or similar descriptive data may be used to indicate flammability, 
reactivity, or similar hazardous properties of the material.
(c) Section III. Physical Data
The data in Section III should be for the total mixture and should 
Include the boiling point and melting point in degrees Fahrenheit (Celsius 
in parentheses); vapor pressure, in conventional millimeters of mercury
(mmHg); vapor density of gas or vapor (air = 1); solubility in water, in
parts/hundred parts of water by weight; specific gravity (water ■ 1);
percent volatiles (indicated if by weight or volume) at 70 degrees 
Fahrenheit (21.1 degrees Celsius); evaporation rate for liquids or 
sublimable solids, relative to butyl acetate; and appearance and odor. 
These data are useful for the control of toxic substances. Boiling point, 
vapor density, percent volatiles, vapor pressure, and evaporation are 
useful for designing proper ventilation equipment. This information is 
also useful for design and deployment of adequate fire and spill 
containment equipment. The appearance and odor may facilitate
identification of substances stored in improperly marked containers, or 
when spilled.
(d) Section IV. Fire and Explosion Data
Section IV should contain complete fire and explosion data for the 
product, including flashpoint and autoignition temperature in degrees 
Fahrenheit (Celsius in parentheses); flammable limits, in percent by volume 
in air; suitable extinguishing media or materials; special firefighting 
procedures; and unusual fire and explosion hazard information. If the 
product presents no fire hazard, insert "NO FIRE HAZARD" on the line 
labeled "Extinguishing Media."
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(e) Section V. Health Hazard Information
The "Health Hazard Data" should be a combined estimate of the hazard 
of the total product. This can be expressed as a TWA concentration, as a 
permissible exposure, or by some other indication of an acceptable 
standard. Other data are acceptable, such as lowest LD50, if multiple 
components are involved.
Under "Routes of Exposure," comments in each category should reflect 
the potential hazard from absorption by the route in question. Comments 
should indicate the severity of the effect and the basis for the statement, 
if possible. The basis might be animal studies, analogy with similar 
products, or human experiences. Comments such as "yes" or "possible" are 
not helpful. Typical comments might be:
Skin Contact— causes delayed burns.
Eye Contact— some pain and transient irritation.
"Emergency and First Aid Procedures" should be written in lay 
language and should primarily represent first-aid treatment that could be 
provided by paramedical personnel or individuals trained in first aid.
Information in the "Notes to Physician" section should include any 
special medical information which would be of assistance to an attending 
physician including required or recommended preplacement and periodic 
medical examinations, diagnostic procedures, and medical management of 
overexposed employees.
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(f) Section VI. Reactivity Data
The comments in Section VI relate to safe storage and handling of 
hazardous, unstable substances. It is particularly important to highlight 
instability or incompatibility to common substances or circumstances, such 
as water, direct sunlight, steel or copper piping, acids, alkalies, etc. 
"Hazardous Decomposition Products" shall include those products released 
under fire conditions. It must also include dangerous products produced by 
aging, such as peroxides in the case of some ethers. Where applicable, 
shelf life should also be indicated.
(g) Section VII. Spill or Leak Procedures
Detailed procedures for cleanup and disposal should be listed with 
emphasis on precautions to be taken to protect employees assigned to
cleanup detail. Specific neutralizing chemicals or procedures should be
described in detail. Disposal methods should be explicit including proper 
labeling of containers holding residues and ultimate disposal methods such 
as "sanitary landfill" or "incineration." Warnings such as "comply with
local, state, and federal antipollution ordinances" are proper but not 
sufficient. Specific procedures shall be identified.
(h) Section VIII. Special Protection Information
Section VIII requires specific information. Statements such as 
"Yes," "No," or "If necessary" are not informative. Ventilation 
requirements should be specific as to type and preferred methods. 
Respirators shall be specified as to type and NIOSH or US Bureau of Mines 
approval class, ie, "Supplied air," "Organic vapor canister," etc. 
Protective equipment must be specified as to type and materials of
construction.
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(i) Section IX. Special Precautions
"Precautionary Statements" shall consist of the label statements 
selected for use on the container or placard. Additional information on 
any aspect of safety or health not covered in other sections should be 
inserted in Section IX. The lower block can contain references to 
published guides or in-house procedures for handling and storage. 
Department of Transportation markings and classifications and other 
freight, handling, or storage requirements and environmental controls can 
be noted.
(j) Signature and Filing
Finally, the name and address of the responsible person who completed 
the MSDS and the date of completion are entered. This will facilitate 
correction of errors and identify a source of additional information.
The MSDS shall be filed in a location readily accessible to employees 
potentially exposed to the hazardous material. The MSDS can be used as a 
training aid and basis for discussion during safety meetings and training 
of new employees. It should assist management by directing attention to 
the need for specific control engineering, work practices, and protective 
measures to ensure safe handling and use of the material. It will aid the 
safety and health staff in planning a safe and healthful work environment 
and in suggesting appropriate emergency procedures and sources of help in 
the event of harmful exposure of employees.
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MATERIAL SAFETY DATA SHEET
1 PRODUCT IDENTIFICATION
M A N U F A C T U R E R 'S  N A M E
R E G U L A R  T E L E P H O N E  NO. 
E M E R G E N C Y  T E L E P H O N E  NO.
A D O R E S S
TRADE NAME
SYNONYMS
II HAZARDOUS INGREDIENTS
M A T E R IA L  O R  C O M P O N E N T % H A Z A R D  D A T A
III PHYSICAL DATA
B O IL IN G  P O IN T  760  M M  HG M E L T IN G  P O IN T
S P E C IF IC  G R A V IT Y  <H20  = l l V A P O R  P R E S S U R E
V A P O R  D E N S IT Y  (A IR  = 1) S O L U B IL IT Y  IN  H jO . %  B Y  WT
%  V O L A T IL E S  B Y  V O L E V A P O R A T IO N  R A T E  (B U T Y L  A C E T A T E  11)
A P P E A R A N C E  A N D  O D O R
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IV FIRE AND EXPLOSION DATA
F L A S H  P O IN T  
(T E ST  M E T H O D !
A U T O IG N IT IO N
T E M P E R A T U R E
F L A M M A B L E  L IM IT S  IN  A IR .  %  B Y  V O L. L O W E R U P P ER
E X T IN G U IS H IN G
M E D IA
S P E C IA L  F IR E
F IG H T IN G
P R O C E D U R E S
U N U S U A L  F IR E  
A N D  E X P L O S IO N  
H A Z A R D
V HEALTH HAZARD INFORMATION
H E A L T H  H A Z A R D  D A T A
R O U T E S  O F  E X P O S U R E  
IN H A L A T IO N
S K IN  C O N T A C T
S K IN  A B S O R P T IO N
E V E  C O N T A C T
IN G E S T IO N
E F F E C T S  O F  O V E R E X P O S U R E  
A C U T E  O V E R E X P O S U R E
C H R O N IC  O V E R E X P O S U R E
E M E R G E N C Y  A N D  F IR S T  A ID  P R O C E D U R E S  
E Y E S
S K IN :
IN H A L A T IO N ;
IN G E S T IO N
N O T E S  TO  P H Y S IC IA N
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VI REACTIVITY DATA
C O N D IT IO N S  C O N T R IB U T IN G  T O  IN S T A B IL IT Y
IN C O M P A T IB IL IT Y
H A Z A R D O U S  D E C O M P O S IT IO N  P R O D U C T S
C O N D IT IO N S  C O N T R IB U T IN G  T O  H A Z A R O O U S  P O L Y M E R IZ A T IO N
VII SPILL OR LEAK PROCEDURES
S T E P S  T O  BE  T A K E N  IF  M A T E R IA L  IS  R E L E A S E D  O R  S P IL L E D  
N E U T R A L IZ IN G  C H E M IC A L S
W A S T E  D IS P O S A L  M E T H O D
VIII SPECIAL PROTECTION INFORMATION
V E N T IL A T IO N  R E Q U IR E M E N T S
S P E C IF IC  P E R S O N A L  P R O T E C T IV E  E Q U IP M E N T  
R E S P IR A T O R Y  ( S P E C IF Y  IN  D E T A IL )
E Y E
G L O V E S
O T H E R  C L O T H IN G  A N D  E Q U IP M E N T
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IX SPECIAL PRECAUTIONS
P R E C A U T IO N A R Y
S T A T E M E N T S
O T H E R  H A N D L IN G  A N O  
S T O R A G E  R E Q U IR E M E N T S
P R E P A R E O  8 Y
A D D R E S S
D A T E
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XII. APPENDIX IV
GLOSSARY*
ALKYLATING AGENTS - Agents capable of introducing an alkyl radical 
into an organic or inorganic molecule by forming a stable carbon covalent 
bond.
BASE-PAIRING RULES - The requirement that adenine must always form a 
base pair with thymine (or uracil) and guanine with cytosine, in a nucleic 
acid double helix.
BASE-PAIR SUBSTITUTION MUTATION - A change of one base pair for 
another base pair, eg, A— T to G— C.
DELETIONS - Loss of a section of the genetic material from a chromo­
some. The size of the deleted material can vary from a single nucleotide 
to sections containing a number of genes.
DNA (Deoxyribonucleic Acid) - A polymer of deoxyribonucleotides. The 
genetic material of all cells.
FRAMESHIFT MUTATIONS - Either deletions or additions of one or more 
but not three or a multiple of three base pairs. In the case of deletion, 
reading of the codon is shifted forward one base and in the case of 
addition, the reading is shifted back one base.
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MUTAGENS - Physical or chemical agents, such as radiation, heat, and 
alkylating or deaminating agents, which may increase the frequency of 
mutation above the observed spontaneous frequency.
MUTATION - An inheritable change in a nucleic acid.
NUCLEOPHILE - An atom or a molecule which can share a pair of 
electrons with an electropositive center in order to form a covalent bond.
POINT MUTATION - Alteration in DNA affecting one or a very small 
number of nucleotides. These alterations can be divided into two main 
subgroups: frameshift mutations and base-pair substitution mutations.
REVERSE (BACK) MUTATION - An inheritable change in a mutant gene that 
restores the original biologic function and, in some cases, the original 
nucleotide sequence.
SPONTANEOUS MUTATIONS - Mutations for which there is no "observable"
cause.
SUPPRESSOR MUTATION - A mutation that totally or partially restores a 
function lost by a primary mutation and is located at a genetic site 
different from the primary mutation.
TRANSLOCATION - The transfer of a section of one chromosome to a 
nonhomologous chromosome.
TRANSDUCTION - Transfer of a portion of one gene to another gene by 
movement of DNA.
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TRANSITION MUTATION - The replacement of a purine by a different 
purine or a pyrimidine by a different pyrimidine in a nucleic acid 
sequence.
TRANSVERSION MUTATION - The replacement of a purine by a pyrimidine 
or of a pyrimidine by a purine.
WILD-TYPE GENE - The form of gene (allele) commonly found in nature. 
♦Adapted from references 68 and 69
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XIII. TABLES AND FIGURES
TABLE XIII-1 
PHYSICAL PROPERTIES OF EPICHLOROHYDRIN
Molecular formula 
Formula weight 
Boiling point
Melting point (freezing point) 
Vapor pressure
Specific gravity (20/4 C) 
Solubility
Flashpoint (open cup)
Saturation concentration 
(in air at 25 C)
Lower explosive limit
Upper explosive limit
Autoignition temperature
Conversion factors 
(760 mmHg and 25 C)
C3H50C1 
92.5 
116.4 C 
-58.1 C
5 mmHg at 5.6 C 
20 mmHg at 29 C 
400 mmHg at 97.4 C
1.1839
6.48% in water; soluble 
in acetone, benzene, 
ether, heptane, and 
methanol
93 F
22,390 ppm
3.8%
2 1 . 0 %
416 C
1 ppm = 3.78 mg/cu m 
1 mg/cu m = 0.26 ppm
Derived from references 2,4, and 5
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TABLE XIXI-2
INDICES OF INTOXICATION IN RATS SUBJECTED TO ONE 4-HOUR 
INHALATION EXPOSURE TO EPICHLOROHYDRIN AT VARIOUS CONCENTRATIONS
Dose 
(mg/l)
Day* Body Temp 
(C)
02 Con­
sumption 
(ml/hr)
Liver 
Weight Co­
efficient BSP Test
Urine
Volume
(ml)
Specific 
Gravity of 
Urine
Chloride 
Content 
in Urine 
(mg/day)
0.35 0 33.4±0.34 235±23.3 4.26±0.18 8.610.30 - - -
1 36.8±0.13 244±20.3 - 0.1 4.410.56 1.02310.006 8.3+1.91
0.02 0 35.5+0.36 275±11.7 4.00+0.18 2.511.30 - - -
1 36.7±0.20 281±16.7 - 3.810.20 4.0+0.54 1.01610.002 5.5+0.54
0.007 0 36.2±0.15 331+19.4 4.11±0.26 1.410.40 - - -
1 37.110.10 318+ 4.8 - 2.810.20 4.9+0.65 1.00910.002 7.111.15
Control 0 36.610.11 426±14.6 3.31±0.17 0.1 - — —
1 36. 9±0.09 410+15.4 - 0.1 2.6+0.72 1.03010.007 3.610.90
♦Observation made immediately after exposure (Day 0) or after 1 day (Day 1)
Adapted from reference 32
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TABLE XIII-3
EVALUATION OF URINE 
OF EPICHLOROHYDRIN-EXPOSED PERSONNEL FOR MUTAGENIC ACTIVITY
Subject
8-hr TWA 
Exposure 
(ppm)
Revertants (Treated)/Revertants (Control)
S typhimurium Strain
1535 1537 1538 100 98
PW1
CBS
TWW
JJM
CBS
PW1
H
DDL
PW1
SJ*
GV*
0.8
1 . 2
1.2 (A)
1.2 (B)
1.5
1.7 (A)
2.6 (B)
3.2 (A)
3.2 (B)
3.5
3.6
4.0
exceeds
25**
exceeds
25**
Average
SD
1.11
0.96
1.271.20
0.93
1.00
0.80
1.16
1.30
0.87
0.62
1.03
2.48
2.64
1.24
±0.59
0.88
1 . 11
0.93
0.87
1.00
0.95
0.84
0.67
0.58
1.00
0.63
0.67
0.24
0.53
0.78
±0.24
1.69
0.69
1.72
1.56
1.25
0.57
0.66
1 . 2 2
1.69
1.13
0.60
1.41
1.12
1.12
1.17
±0.42
1.91
1 . 2 1
0.871.00
1.54
0.93
0.93
2.00
1.79
0.87
0.91
1.61
0.99
1.13
1.26
±0.42
1.78
1.73
0.83
0.58
1.23
1.62
1.31
1.62
1.46
1.00
1.00
1.38
1.21
±0.49
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TABLE XIII-3 (CONTINUED)
EVALUATION OF URINE OF 
EPICHLOROHYDRIN EXPOSED PERSONNEL FOR MUTAGENIC ACTIVITY
8-hr TWA
Subject Exposure Revertants (Treated)/Revertants (Control)
(ppm) ____________________________________________
S typhimurium Strain
1535 1537 1538 100 98
WR Control 1.24 0.54 0.88 1.00 1.08
RWV 11 0.86 1.04 1.19 1.58 1.00
SRR 11 0.89 0.13 0.94 1.70 0.76
LAS II 1.08 0.42 1.22 2.21 1.03
L rr 0.78 0.63 0.98 0.57 0.89
Average 0.97 0.55 1.04 1.41 0.95
SD ±0.19 ±0.33 ±0.15 ±0.64 ±0.13
*Acute exposure
**Average area monitoring results during 105 min 
From DJ Kilian (written communication, April 1976)
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OH XR H XR OH H
M l  M l
+ R X H -------------->  H - C - C - C - C L  or H -C -C -C -C L-** I I I  T i l
H H H H H H
X = an electronegative element such as oxygen 
nitrogen, or su lfur
R = an alkyl or aryl or other organic group.
By the law of mass action, the rate of reaction of epichlorohydrin with a nucleophile 
is given by:.
d [CH2 OCHCH2CL] = k [CH2OCHCH2 CU [RXH] 
dt
where k = a rate constant
/ \  I 
H -C -C -C -C L  
i i I 
H H H
where
where
REACTION 
OF 
EPICHLOROHYDRIN
FIGURE XIII”2
CALIBRATION SETUP FOR PERSONAL SAMPLING PUMP WITH CHARCOAL TUBE
Soap Bubble 
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(inverted buret)
&
500
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water
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